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 II ABSTRACT  
 
Population databases containing allele frequencies of the genetic markers used for DNA-
profiling are necessary for forensic geneticist to be able to perform statistical calculations on 
the statistical weight of DNA-evidence. However, allele frequencies differ from population to 
population, it is therefore important to establish population databases for specific graphical 
areas or population groups. The Center of Forensic Genetics is currently using a method based 
on PCR and capillary electrophoresis for DNA-profiling, but wants to establish a method based 
on deep sequencing. 
The purpose of this study was therefore to establish a population database for a Norwegian 
population with allele frequencies of autosomal STR markers used for DNA-profiling with the 
new NGS-based method. Samples from a previously established biobank were used to obtain 
DNA profiles for all 231 forensic genetic markers included in the ForenSeq DNA Signature 
Prep kit. Validation data of the ForenSeq FGx system was also assessed, focusing only on the 
27 autosomal STR included in the kit. 
The Norwegian population database for autosomal STRs was established, with frequencies of 
both length-based and sequence-based allele variants. There is an increase in the number of 
sequence-based allele variants compared to length-based allele variants for many markers, 
meaning the power of discrimination can be raised when using the same number of markers 
when using a deep sequencing method. A reproducibility and sensitivity study of the ForenSeq 
FGx system was also conducted. They showed that the system produces 100% reproducible 
genotypes when sequencing the same samples more than once. The sensitivity study showed 
that with the ForenSeq FGx system a complete DNA-profile can be obtained for 125 pg DNA, 
and that approximately 50 % of alleles can still be called with as little as 15.625 pg DNA. To 
check if the two methods, Signature Prep and the NGM Select, could produce the same 
autosomal genotype results, a concordance study was performed. Almost full concordance was 
found between the two methods, only three alleles had discordances. The discordance is 
probably because of two different primers being used for the kits. They might been bound 









In a small town in Northern Norway, a young girl has been found murdered and left in a field. 
After some fieldwork, the crime scene technicians and police have a prime suspect named Mr 
Petersen, a 44-year-old man who lives not far from the crime scene. Upon further investigation, 
they now know that his DNA profile matches the mixed DNA profile obtained from skin cells 
underneath the young girl’s fingernails. The question remains, did in fact MR Petersen 
contribute this DNA sample. How many other people could have a DNA-profile matching the 
DNA-profile of the stain? And what is the probability for that? To answer these questions, the 
statistical weight of the evidence is calculated using allele frequencies for the genetic markers 
included in the DNA profile from a relevant population database.  
In 2016, the Centre of Forensic Genetics (FGC), Institute of Medical Biology, Faculty of Health 
Sciences (UiT) started a research biobank and began to collect data to build a Norwegian 
population database with allele frequencies of the genetic markers used for DNA-profiling. This 
study will complete the database so that the obtained allele frequencies can be used to calculate 
the statistical weight of DNA-evidence to answer the questions above mentioned.  
The human body consist of approximately 100 trillion cells, and each of these contains DNA 
with genetic information unique to each individual (1). The unique information found within 
each individuals DNA can be used in correlation to criminal cases. DNA analyses of biological 
samples are conducted with the purpose of characterizing single noncoding sites in the DNA of 
an individual. A DNA profile is the collection of these characterized sites in the DNA. The 
DNA profiles become unique to each individual if enough sites (genetic markers) are included 
into the profile, therefor individuals can be identified though their DNA profile.  
To determine if an individual might be involved in a crime, their DNA profile can be compared 
to the DNA profile obtained from a crime scene sample. An individual may be connected to a 
case due to different involvements. The individual might for example be the perpetrator, the 
victim or the police officer working on the particular case (2).  
Today, the Short Tandem Repeats (STRs) are the genetic markers most widely used in forensic 
genetics. However, other methods have been previously used until the end of the 1990s, such 






In 1990, the Austrian researcher Karl Landsteiner at the University of Vienna discovered that 
blood from different people would occasionally clump together. This lead to his eventual 
identification of the four blood types A, B, AB and O. The ABO blood group system was the 
first genetic evidence used to identify individuals in court in 1915. Professor Leone Lattes at 
the institute of Forensic Medicine in Turin developed methods for typing dried bloodstains with 
antibodies for the ABO blood groups. His method spread throughout Europe and to the United 
States, and over the next decades the ABO typing method was used in forensic cases and 
paternity disputes. However, large amounts of blood were needed for samples to be analysed, 
and the marker had low discriminatory power considering that there are only a few blood types 
in a population. In addition, the genetic markers were very susceptible to environmental 
degradation (1).  
In 1984, the British geneticist Sir Alec Jeffreys discovered a region in the chromosomes that 
were built of blocks of repetitive DNA, like a barcode. The blocks where present in all humans 
and specific in length to each individual. This meant that they could be used to distinguish 
between two people, similar to fingerprints. These areas were therefore titled DNA fingerprints. 
The repetitive blocks of DNA were later known as Variable Number of Tandem Repeats 
(VNTRs). Jeffreys used a method called Restriction Fragment Length Polymorphism (RFLP) 
to analyse them (3, 4).  
Since the DNA fingerprints were relatively unique between individuals, Sir Alec Jeffreys 
thought they could be useful in criminal cases. The first criminal case was solved in 1983 by 
DNA fingerprinting. A 15-year-old girl was found raped and murdered in Leicestershire. 
Although a semen sample was retrieved from the body, all investigation came to a halt and the 
case went cold. Three years later, another 15-year-old girl was found raped and murdered with 
a semen sample present on the body. Initially, the prime suspect was 17-year-old Richard 
Burkland, who under questioning admitted he was responsible for the second crime and had 
knowledge of the body. However, with Sir Alec Jeffreys’ DNA-fingerprinting method, it was 
discovered that the two semen samples from the cases in 1983 and now in 1987, came from the 
same individual and that the DNA did not match Burkland. Therefore, the Leicestershire 
Constabulary and the Forensic Science Service conducted a large-scale search to find the 
perpetrator. Approximately 5000 local men were asked to give a blood and saliva samples, but 
none of the samples matched the semen samples. Later it was discovered that a man named 
Colin Pitchfork had payed someone to give a DNA sample in his name. He was arrested was 





samples found at the crime scenes. He confessed to the two crimes and was sentenced to life 
imprisonment. This was the first criminal case solved with DNA evidence. DNA profiling as a 
valuable tool for solving crimes was hereby established (1, 5).   
The first case in Norway was solved by DNA-analysis shortly after, in 1989. 17-year-old Inger 
Lise Olsen was raped and murdered in Mysen. After several weeks the police did not yet have 
a suspect. They then asked male residents to provide a blood sample in large-scale search. Based 
on these samples an 18-year-old man was convicted on the basis of a DNA match (6, 7).  
The RFLP method used by Jeffreys consists of DNA samples being fragmented by restriction 
enzymes. The enzymes recognize specific nucleotide sequences in the DNA samples and cut 
the DNA strands. Then the fragments are separated according to their lengths by gel 
electrophoresis, see figure 1. RFLP as a method requires large amounts of DNA. This factor 
made DNA fingerprinting difficult in cases with low amount and/or degraded DNA samples. 
With the invention of Polymerase Chain Reaction (PCR) by Kary Mullis (8), only a drop of 
blood is needed to successfully obtain a complete DNA profile.  
DNA itself is a very stable molecule, so it can easily be typed accurately even if blood and 
bodily fluids are degraded. RFLP of DNA samples was replaced by PCR of Short Tandem 
Repeat markers (STRs). The obtained DNA fragments were visualized by electrophoresis 
which has been further developed into today’s capillary electrophoresis (CE) (3, 9-11). Today’s 
DNA profiling method was largely developed in thanks to these two independent breakthroughs 
in molecular biology by Professor Sir Alec Jeffreys and Kary Mullis. One of the most exciting 
DNA profiling methods today is Next Generation Sequencing (NGS), a method that will be 








Figure 1. The human DNA fingerprint, achieved by analysing specific DNA segments with Restriction Fragment 
Length Polymorphism. In this picture, Sir Alec Jeffreys is holding up a film that has been exposed over the gel. 
Modified from: (3).  
 
 STRS AND DNA TYPING  
The human genome consists of about 3 million base pairs, and although it is large, 
approximately 5% contains genetically relevant information also known as the gene-coding 
DNA. The other ~95% contains non-coding DNA and is in some parts built up of repeated 
sequences. Although the human genome is largely similar between individuals there are still 
parts with enough diversity to be able to distinguish between people. Short Tandem Repeats are 
simple repeated blocks of DNA, which are highly polymorphic spots in the non-coding DNA 
regions. STRs consist of short DNA-motives of 2-7 base pairs in length that are typically 
repeated 5-50 times and they are located around the centromere of the chromosomes (1, 12-14). 
STRs used in forensic genetics are mainly tetranucleotides, which are sequence motives of 4 
base pairs. The chosen STR-markers are spread over as many chromosomes as possible to 
ensure that they are inherited independently. The independence of the STR is important when 
performing statistical analysis. If the STRs are closely linked, they may not be randomly 
distributed throughout a population.  
STRs have different qualities that make them suitable for human identification. The STR alleles 
vary among individuals and some are more common than others. Allele frequencies vary 
between populations, making STRs quite effective in separating individuals also between 
populations. Forensic DNA evidence can often be quite degraded and it can be challenging to 





makes them ideal targets for use in forensic genetic. The data obtained by analysing STR is 
rather stable and predictable because STR alleles have low mutation rates (15, 16).  
Each individual inherits one STR copy from each parent, therefore the locus will show two 
possible alleles (17). If the two copies have the same repeat numbers, the individual will be 
homozygote for that marker. If the two copies inherited have different repeat numbers, the 
individual is heterozygote for that particular marker. Homozygote and heterozygote STR loci 
are shown under STR loci 1 and 2 in figure 2, respectively. By examining enough STR markers 
each individual will obtain a specific DNA profile (Fig. 3) which will distinguish them from 
others (13). A DNA profile consists of all the allele lengths numbers of each included STR 
marker. In figure 3, the DNA profile is visualized by an electropherogram. Each STR marker 
has one or two peaks (heterozygous or homozygous), which visualises the alleles. The number 
beneath these indicates the allele number, which is equivalent to the number of times the STR 
tetranucleotide motif is repeated. For example, the individual in figure 3 is heterozygous for 




Figure 2. Two different STR loci in the DNA profile of an individual, one with an equal number of repeats and the 
other with different number of repeats in the two copies inherited from the individual’s parents. This individual 
has inherited two alleles 7 at STR locus 1, so it is homozygous at this locus. STR locus 2 contains alleles 8 and 13, 








Figure 3.  An electropherogram of a DNA profile containing 15 STR markers and one sex marker. Modified from 
(19).  
Replication errors known as replication slippage can lead to mutations in STRs. During 
replication the DNA polymerase dissociates (slips) from the DNA template and anneals to 
homologous sequences nearby. This error is prone to happen in regions of repetitive DNA, 
leading to deletions or insertions of a repeat in the sequence (20, 21). Therefore, STRs have 
usually length polymorphism, but point mutations altering the sequence within one of the 
repeats or the flanking region may also occur. Any changes that do not alter the length of the 
fragment are not possible to detected by electrophoresis, but only by sequencing. NGS is a 
method that can detect these alterations, by characterizing sequence variations within alleles. 
Table 1 shows different variants of the D12S391 marker with the same allele number, but 
different sequences. The detection of these sequence differences can be helpful in further 







Table 1. Example of different alleles in the STR marker D12S391 with the same fragment length (allele number 










DNA profiles can be stored in a DNA database. The DNA database contains a collection of 
computer files with DNA profiles obtained from crime scenes or DNA profiles that are 
connection to these. In Norway, there are currently three different DNA databases/registers. 
The investigation register contains the DNA profiles of individuals and trace sample evidence 
under investigation. Second, the identity register containing the DNA profiles of convicted 
individuals. Third, the trace sample register containing the DNA profiles of crime scene 
samples not yet identified. DNA databases have been and can be very useful in solving cases. 
They can be used to connect serial crimes, as well as resolve cases in which there initially have 
been no suspects. Unjustly incarcerated or charged individuals can be exonerated when the real 
offender might show up in the database later in connection to another crime. The DNA profiles 
in the investigation register are either deleted if the individual investigated is acquitted or 
transferred to the identity register if they are convicted. Unsolved trace samples are transferred 
to the trace sample register, and the different registers can be searched against each other. The 
databases make the connection between cases and DNA profiles (22).  
To be able to compare unknown crime scene DNA profiles and search databases between 
countries and laboratories, there is a need to agree on a set of common STR markers. In order 
to achieve this, the Combined DNA Index System (CODIS) was established by the FBI 
Laboratory in1996. The CODIS consists of the 13 most common autosomal STR markers used 
for identification purposes. All 13 STRs have a high power of discrimination, which makes 
them suitable for forensic casework. These loci are internationally recognized as the standard 
for human identification. The 13 CODIS loci are CSF1PO, FGA, TH01, TPOX, vWA, 





In 1999, the DNA working group of the European Network of Forensic Science Institutes 
(ENFSI) established the European Standard Set (ESS), which consisted of 7 core loci also found 
in CODIS: TH01, vWA, FGA, D21S11, D3S1358, D8S1179 and D18S51. In order to raise the 
power of discrimination, Gill et al. suggested the addition of five new loci; D10S1248, 
D22S1045, D2S441, D12S391 and D1S1656. This increased the ESS core STR loci set from 7 
to 12 (23-26). The number of ESS markers has recently been increased further with D2S1338, 
D8S1179, D16S539, D19S433 and D1S165 (27).  
By expanding the number of markers used, the discrimination power increases. When the 
discrimination power increases it becomes easier to differentiate between individuals because 
the DNA profile become more complex. The robustness of the results can also improve by 
raising the power of discrimination. In addition to this, different markers have higher sensitivity 
when analysing degraded/ smaller amount of DNA (25).  
As previously mentioned, the marker most widely used for DNA profiles are usually STRs. 
However, there are other markers suitable for identification purposes and additional analysis, 
such as single nucleotide polymorphisms (SNPs), markers on the Y-chromosome or 
mitochondrial DNA. 
The Y chromosome is different from the other chromosomes because it is inherited (almost) 
intact from the father to the son. This means that the chromosome can be traced back in the 
male lineage in families, giving the genetic markers on the chromosome a valuable role in 
forensic genetics. Y-STRs are especially useful in separating male DNA in mixtures where 
there is a great excess of female DNA, as for instance in vaginal samples in rape cases.  
Like the Y chromosome, mitochondrial DNA (mtDNA) is passed from generation to 
generation, but solely in the maternal lineage. This enables its DNA to be traced backwards in 
families. There are also multiple copies of mtDNA in each cell, making it not only useful for 
ancestral research but also suitable for cases involving extremely low amounts of DNA or 
degraded samples. Mitochondrial DNA is also small in size, has a high mutation rate and a lack 








 ALLELE FREQUENCIES AND POPULATION DATABASES 
Population databases are collections of allele frequencies from groups of representative samples 
from a population. Allele frequencies are equivalent to the probability for a specific allele to be 
found in that specific population. Allele frequencies differ from population to population, which 
is why it is important to make population databases for each country or geographical area. For 
example, if a suspect matches the obtained DNA profile from a crime scene, different 
calculations can be performed to assess the rarity of this specific profile in a specific population 
or population group. The occurrence of a certain DNA profile might be more common in for 
example the subpopulation of European ancestry compared to the subpopulations of Hispanic 
or African ancestry in the United States.  
To reliably estimate the allele frequencies in a large population it is sufficient to obtain a sample 
size greater than n=100 (28). Allele frequencies are obtained by dividing the number of times 
the allele is observed in the population by the total number of allele copies examined in that 
particular genetic locus. Allele frequencies are a direct reflection of the genetic diversity within 
a population. The probability of a specific DNA profile occurring in a given population can be 
calculated using the allele frequencies in a population database. Changes to the allele 
frequencies over time may indicate genetic drift or new mutations occurring in a population (1, 
12, 29).  
When an individual’s DNA profile is found to match an obtained DNA profile from a crime 
scene, the individual may be considered the suspect or perpetrator of the crime. How many 
other people, apart from the perpetrator, could have contributed to this sample? Statistical 
calculations, such as Random Match Probability (RMP), Random Man Not Excluded (RMNE) 
or Likelihood Ratio (LR) can be used to answer that (1). These methods have all in common 
that the they in some way or another consider the probabilities of possible genotypes/allele 
combinations for each of the loci in a population. These probabilities can be calculated using 









 NEXT GENERATION SEQUENCING 
New NGS technology is about to replace CE-based methods for DNA analysis. Before we can 
understand the sequencing methods used today, it is important to understand where and how it 
all began. DNA sequencing was first described in 1977 by Sanger et al. (30) and Maxim Gilbert 
(31). Sanger sequencing by CE is known as the gold standard for DNA sequencing. DNA 
sequencing allows to decode the nucleotide sequence of a DNA sample.  
The Sanger method utilizes a DNA primer, DNA polymerase, deoxynucleotide triphosphates 
(dNTP) and dideoxynucleotide triphosphates (ddNTPs) with different fluorescent labels for 
each nucleotide. The DNA sample is denaturated yielding a template strand, where the primer 
anneals. The DNA polymerase starts to build the complementary strand with the dNTPs. At 
different stages one ddNTP is added to the reaction mix and its addition results in the halt of 
the DNA synthesis at random places on the DNA-strand. The result is a range of different DNA 
fragments with various0020lengths. The fragments are analysed by capillary electrophoresis, 
sending the fragments through polymer-filled capillaries. In addition, the fragments pass 
through a detection cell with a laser measuring the fluorescent strength of all the DNA 
fragments passing. Thus, in addition to separating the fragments by size they are separated by 
fluorescence. By combining fluorescence and fragment size, the DNA sequence is assembled. 
Originally, this reaction was divided into four different tubes, where only a single type of 
ddNTP would be added, one for each nucleotide. The fragments were separated on an 
acrylamide gel, where the gel bands had to be read manually. With further improvements over 
several years the method has been made more efficient and accurate which now allows a 
computer to read the sequence (32).  
New sequencing technologies called Next Generation Sequencing or massive parallel 
sequencing (MPS) have been developed since then. NGS has revolutionized genomic research 
with its high speed, scale and throughput. It enables researchers to perform analysis and 
applications in biology like never before. Using Sanger technology, it took around a decade to 
sequence the entire human genome in the Human Genome Project, but this can be achieved 
within a few days using NGS (33). For instance, a single run on the Genome Analyzer 
(Illumina) in 2005 would produce approximately one Giga base of data, whereas in 2014 the 
amount was increased a 1000-fold to 1.8 Terra bases. The cost of sequencing has also dropped 
considerably, from 3 billion dollars (The Human Genome Project) to approximately 1000 





input has also risen with multiplexing. Multiplexing allows to pool and sequence many libraries 
simultaneously. This is possible by using unique index sequences that are added to each DNA 
fragment during library preparation. The indexes help identify and sort the reads before final 
data analysis (1, 34-36).    
 
1.3.1  NGS AND FORENSIC GENETICS 
Several NGS platforms and methods have become available during recent years, allowing for 
large-scale production of genomic sequences. In addition, the number of human genomes 
sequenced is rapidly increasing. NGS technology enables to sequence several thousand copies 
of short DNA fragments in multiple individuals simultaneously (37). In forensic genetics the 
MiSeq FGx Forensic Genomic System from Illumina, the Ion Torrent PGM and the S5 from 
Thermo Fisher Scientific are the most common NGS platforms used (32). Within genomic 
research, NGS allows for complex genetic studies that are not technically or economically 
practical with the Sanger sequencing method alone (35).  
Sequencing of the whole genome is known as whole-genome sequencing or shotgun sequencing 
where no prerequisites are made. However, in forensic genetics there is usually no need to study 
entire genomes. It is more interesting, that a range of specific parts (targets) of the genome can 
be analysed and sequenced in parallel. The sequencing of specific genes is known as targeted 
sequencing, which is the method used in this study (38). In forensic genetics, targeted 
sequencing is the preferred method over shotgun sequencing. As it allows for a more precise 
analysis, saving not only time but sample. In comparison to other fields, forensic genetic DNA 
analysis is challenging because of the low amounts of DNA and/or degraded DNA in the 
samples obtained, because there is also a need for high accuracy and reproducibility and 
samples may contain DNA from more than one individual (39). NGS can not only replace 
Sanger sequencing, but it can also be used for markers that have previously been analysed by 
other methods, such as STRs with CE, SNPs with Snapshot and RNAs with quantitative PCR. 
Some NGS platforms are similar in method and workflow, even though the technical 
differences and sequencing biochemistry might be different. The platforms method broadly 
consists of library preparation, sequencing, imaging and data analysis (40). Methods such as 
hybridization- and amplicon-based enrichments are used for targeted sequencing. Amplicon-





which is mixed with the sample. In a second PCR reaction, the sequences are amplified and the 
tags are attached to the adapter sequences and indexes. Hybridization-based enrichments 
utilizes DNA “baits” that represent the target sequences. The sequences hybridize with the 
“bait” molecule to pull them down for sequencing. Adapter sequences are used for clonal 
amplification, and indexes are used to identify the sample. Indexes allow for mixing many 
samples together in one tube, so that they can be sequenced simultaneously. The number of 
samples that can be analysed together depends on several factors: the number of indexes used, 
the capacity of the NGS platform, the sequencing depth, and the number and sizes of the 
targeted regions (37, 38, 41, 42).  
After library preparation, the amplicons are clonally amplified in clusters to create measurable 
amounts for sequencing. The amplification of fragments can be done by bridge PCR, a process 
in which the PCR amplicons are clustered on a planar substrate (such as a flow cell). Each 
cluster is a sequencing target and is sequenced in parallel on a chosen NGS platform (42). 
Sequencing of the clusters is done in real-time using either pyrosequencing, semiconductor 
sequencing, sequencing by synthesis or sequencing by ligation. Sequencing capacity is the total 
number of clusters or reads sequenced per run, which varies significantly between different 
platforms. For example, the MiSeq FGx Forensic Genomic System from Illumina can sequence 
5 to 400 million clusters in 2 to 55 hours, and the HiSeq 2500 System from Illumina can 
sequence up to four billion clusters in five to eleven days. Figures 4, 5 and 6 show schematic 
drawings of the first three methods used for next generation sequencing. In pyro- and semi-
conductor sequencing, the nucleotides are added sequentially. Attached nucleotides generate 
light signal, which is then detected and interpreted (41).  
However, it can be difficult with these methods to distinguish exactly how many nucleotides 
there are in sequences with more than five homopolymers (nucleotides of the same type) (38). 
This problem is not relevant in sequencing by synthesis. With this method, all four nucleotides 
are added at the same time, but only the complementary nucleotide actually attaches to the 
sequence. All the nucleotides are blocked in the 3’ end, stopping further elongation of the 
molecule. Sequencing by ligation utilizes DNA ligase and probes labelled with fluorescence 
fragmented genomic DNA. Florescent signals from different clusters are produced during 







Figure 4. Overview of pyrosequencing. The addition of one nucleotide at a time releases pyrophosphate that is 
converted into ATP by sulfurylase and then into light by luciferase. Modified from (44). 
 
 
Figure 5. Sequencing by synthesis. Fluorescently labelled nucleotides are added to the template DNA strand. 
Addition of a new nucleotides releases a specific fluorescence signal, and the DNA sequence can be typed.  Since 
the nucleotides have terminated ends, they must be removed for another nucleotide to attach by DNA polymerase. 
After each nucleotide addition, a camera detects the emitted light that corresponds to a base and the DNA is 
sequenced. Modified from (45).   
 
 
Figure 6. Semiconductor sequencing technology. The addition of a nucleotide to a DNA strand releases a 
hydrogen ion. The ion changes the pH value in the solution, which is detected by an ion sensor. The pH change is 
specific to each nucleotide when the change is noticed the nucleotide will be called and added to the sequence. 





Illumina has developed a specialized sequencing system for use in forensic genetics, the MiSeq 
FGx Forensic Genomics System. This instrument has two modes, research and forensic, and the 
latter is used in this study. Sequencing with the research mode is the same as the standard MiSeq 
instrument (46). The workflow of this system for forensic use consists of all steps from library 
preparation of input DNA to the processing of sequenced data. This has been the first fully 
validated sequencing system intended for forensic genomics applications. The MiSeq FGx 
Forensic Genomics System Workflow is illustrated in figure 7 (47). The Signature Prep kit 
contains the necessary reagents to prepare the libraries, and includes primers for targeted PCR 
amplification of 230 STR- and SNP-regions in the human genome relevant in forensic genetics, 
(48). Two primer sets are provided, DNA primer mix A (DPMA) and DNA primer mix B 
(DPMB). Primer mix A contains primer pairs for 58 STRs (27 autosomal STRs, 7 X-STRs and 
24 Y haplotype markers) and 94 identity-informative SNPs. Primer mix B  is the one used in 
this study, containing primers for the same markers as DPMA in addition to 56 biogeographical 
or ancestry-informative and 24 phenotype-informative SNPs (46, 47). In this study, only 
sequencing results for the 27 autosomal STR-markers have been processed further. 
 
 
Figure 7. The MiSeq FGx Forensic Genomics System Workflow consisting of four steps: 1. Preparation of input 
DNA, 2. Library preparation, 3. Sequencing and 4. Data analysis. Modified from (47).  
 
Several studies have shown that sequencing by ligation has the lowest error rate among NGS 
methods, followed by sequencing by synthesis, semi-conductor sequencing and pyrosequencing 
(49-51). Because the error rates are from genome sequencing studies, they can be misleading. 
The errors are unevenly distributed and are often related to specific sequence elements, for 
example sequencing of homopolymer regions. It is therefore too simple to state that sequencing 
by ligations is the best technology for forensic genetic application. To properly evaluate the 





The standard STR-analysis method today is usually carried out by PCR and CE. The new 
technology for STR-analysis is based on deep sequencing (NGS). Individual assays for 
autosomal STRs and SNPs, Y chromosome STRs and SNPs, X-chromosome STRs, indels, 
mtDNA, ancestry-informative SNPs (AIMs) and phenotype-informative SNPs are all examples 
of the main forensic markers typed with PCR-CE. Although PCR-CE can be performed in one 
day and NGS takes 2-3 days, only 30-40 SNP-markers and even fewer STR-markers can be 
analysed with CE based methods at a time. The advantage of NGS is that several more markers 
can be analysed in one assay. In addition, different types of markers can be combined in one 
assay, as for example SNPs and STRs in the ForenSeq DNA Signature Prep kit (Illumina) used 
in this study. Although not relevant in this study, it allows for the analysis of an individual’s 
STR-profile and the SNPs to elaborate on this particular person’s physical appearance and 
ancestry. This will both save time and the amount of DNA sample used. These factors are 
extremely important in casework if additional DNA analysis is needed as an investigative lead 
and/or if the sample volume is low from the start (41).  
Another advantage is the ability to analyse degraded DNA because of the short amplicons in 
most of the markers used. Apart from fragment length, sequence variation within the repeat and 
flanking region of the STRs can be obtained, increasing the discrimination power. It is also 
desirable to gain more knowledge about sequence variation in different populations (41, 52, 
53). 
 
1.3.2 SEQUENCE VARIATION 
As previously mentioned, STRs are widely used as genetic markers for forensic DNA analysis. 
DNA databases around the world contain millions of valuable STR profiles, which is why STRs 
will be the preferable genetic markers for DNA profile analysis also in the future (54, 55). 
However, this does not exclude the ability to extract more information than is normally done 
from STRs today. Apart from fragment length, sequence variation within these markers can be 
explored. In Hussing et al. 2018 (56) they found no differences in STR typing results between 
CE and the sequencing method using length-based alleles. But with sequenced-based alleles we 
can explore the nucleotide composition of each marker. Meaning that the additional information 
of the markers can give further discrimination power when analysing samples. This can be very 





Traditionally, STR analysis is performed by a size-based DNA separation either using gel 
electrophoresis or CE. However, PCR product length alone does not identify the eventual 
variations found within the STRs (57, 58). On the other hand, NGS can identify the variation 
within the STRs in addition to the lengths traditionally examined. With the ability to examine 
the sequence variation within STR alleles, the number of effective alleles may increase (59). In 
addition, this can lead to the separation of samples where two individuals may have the same 
length-based STR allele (see figure 8) (60),. This was explored by Novroski NMM et al. (53) 
who used the MiSeq FGx Forensic Genomics System (Illumina), STRait Razor and in-house 
Excel workbooks to characterize the genetic variation within STR repeats and flanking regions 
of 27 autosomal, 7 X-chromosome and 24 Y-chromosome STR markers in 777 unrelated 




Figure 8. Two individuals having the same STR repeat number/length-based allele for a specific STR locus, but 
in fact with two different sequences within the STRs. Modified from: (18).  
 
The Centre of Forensic Genetics is currently using the NGM SElect kit (Thermo Fisher 
Scientific) as a standard method for DNA profiling of STR markers. This method is based on 
PCR of the included autosomal STR markers and fragment length analysis by capillary 
electrophoresis. However, they are considering to test and implement a sequence-based DNA 
profiling method as well, using the MiSeq FGx Forensic Genomic System, consisting of the 






FGC started this work in August 2016. After some initial problems with library preparation, the 
method is working reliably now (2). In forensic genetics, there is a constant dedication to 
improve the technology and methods used in order to obtain more and better information from 
samples containing little DNA. The implementation of a new method demands thorough testing 
and validation. The manufacturer performs a comprehensive developmental validation, but 
each laboratory has to perform an internal validation to ensure that the new method is reliable 
according to the manufacturer’s documentation. Validations are usually carried out according 
to international recommendations and guidelines (62, 63), testing the reproducibility and 
sensitivity of the method and also concordance with different methods if possible. FGC plans 
to validate the Signature Prep kit, and some of the data obtained during this master project will 
contribute here.  
To calculate the statistical weight of DNA evidence, a population database must be established 
for all allele frequencies of the STR-markers included in the specific analysis method used. 
There is already a Norwegian population database available, but it is currently limited to 10 
autosomal STR markers (https://strider.online/frequencies). If the MiSeq FGx Forensic 
Genomic System is to be implemented in the future, there is a need to establish the allele 
frequencies for the extra STR markers. FGC has established a research biobank in 2016 
containing more than 500 blood samples, with the purpose, among others, to establish the 
Norwegian population database with allele frequencies for autosomal STR-markers. 
Approximately half of the samples were already sequenced with the ForenSeq DNA Signature 
Prep kit in a previous project looking at phenotype-informative SNPs (46). The other half of 
the biobank samples still needs to be sequenced to obtain a full dataset for autosomal STR 












 AIMS OF STUDY 
 
• Finalize the ongoing sequencing project on the Norwegian population sample from the 
research biobank established at FGC. The aim is to obtain as many complete DNA profiles 
for all 231 forensic genetic markers included in the ForenSeq DNA Signature Prep kit as 
possible. This is done to enable the biobank to be utilized also in future projects.  
 
• Establish validation data for the MiSeq FGx Forensic Genomic System with focus on the 
27 autosomal STR-markers included in the Signature Prep kit: 
 
o Performance of the MiSeq FGx Forensic Genomic System using data from 
representative runs with libraries prepared using two different reagent lots of the 
Signature Prep kit 
o Reproducibility of genotyping results  
o Genotype concordance between the 15-overlapping autosomal STR-markers included 
in both the Signature Prep and the NGM SElect kit, which is the current standard method 
for DNA-analyses at FGC 
o Sensitivity: establish the amount of DNA in a sample for which a full DNA profile for 
autosomal STR-markers can be obtained 
 
• Establish the population database of autosomal STR allele frequencies for Norway based 
on fragment length, which can be used to calculate the statistical weight of DNA-evidence 
in criminal cases in Norway.  
 












2 MATERIALS AND METHODS 
 
The DNA samples used in this study were taken from a research biobank established in 2016 
by the Centre of Forensic Genetics, Institute of Medical Biology, Faculty of Health Sciences, 
UiT The Arctic University of Norway. There is a total of 540 DNA samples in the Biobank. 
Two previous master students in the research group helped to collect and process the samples 
(38, 46). Therefore, DNA extraction and quantitation of most of the samples used in this study 
was already carried out. I extracted the DNA and performed quantitation analysis on the 
remaining samples.  I prepared libraries and sequenced approximately half of the biobank 
samples. The other half of the samples was already sequenced previously (38, 46), and the 
sequencing data was used in this study.  
 
The biobank samples used in this study were all analysed using the reagent kits listed in Table 
2. Unless otherwise specified in the protocols, all reagents were vortexed and spun down 
quickly before use.  During this study, different lots of the ForenSeq DNA Signature Prep kit 
and the MiSeq FGx Reagent kit have been used. Validation of the MiSeq FGx Forensic 
Genomic System was also assessed, focusing only on the 27 autosomal STRs in the Signature 
Prep kit. By finalizing the sequencing of all the biobank samples, a Norwegian population 
database of the autosomal STR allele frequencies based on fragment length was consequently 
built.  
 
Table 2. Overview of all reagent kits used in this study. 
Kit Distributor Purpose 
QIAamp DNA investigator 
kit 
Qiagen DNA extraction from blood 




Quantitation of human DNA in DNA 
extracts 
Qubit ds DNA HS assay kit Invitrogen, ThermoFisher 
Scietific 
Quantitation of purified libraries for 
Next Generation Sequencing 
ForenSeq DNA Signature 
Prep kit 
Illumina Inc. DNA Library preparation for Next 
Generation Sequencing 
MiSeq FGx Reagent kit Illumina Inc. Sequencing reagents and flow cell 








Research biobanks can contain human tissue samples gathered for clinical and research 
purposes such as microscopy. These biobanks can be based on population studies or patient 
based studies. In addition, biobanks can contain medical information about the donors. The 
information and samples can be stores for a long period of time to ensure that long term future 
research projects can be accomplished. Extra information regarding the donors and samples is 
registered and documented and may consist of questionnaires, pictures, observations and/or 
measurements. Tissue samples from the donors may consist of blood, saliva, skin biopsies or 
even whole organs if the donor has passed away (64, 65).  
The DNA samples used in this study were taken from the research biobank established in 
2016/2017 at the Centre of Forensic Genetics. All data and samples were collected 
anonymously. Storage and usage of the information in the biobank for this project was approved 
by the Norwegian Data Protection Authority (DPA) (Reference DPA: 15/00367-3/CGN). Blood 
sample collection of consenting volunteers was done at various public institutions in Northern 
Norway, such as the Faculty of Health Science and the Faculty of Law at the University of 
Tromsø, the police units in Tromsø and Bodø as well as the Norwegian Police University 
College in Bodø. The samples were stored in EDTA tubes, containing 500-1000 µl of blood 
each. The sample donors were between 20 and 69 years of age, 73.4% of them were women 
and 26.6% were men. They all signed an informed consent document. Additionally, digital 
images and/or colour measurements were taken from each donor’s eye, hair and skin. Donors 
also answered a questionnaire containing questions about gender, height, phenotypic traits and 
heritage (e.g. the birthplace of all their grandparents) (38, 46). However, the additional 
information obtained by these questions were not relevant for this study. The purpose of 
establishing this research biobank was to obtain a representative sample of the population of 
Northern Norway, i.e. the people that live here, for studies in forensic genetics. This is the 
reason why the biobank also includes samples from individuals that are not born and raised in 
this particular part of Norway or even have foreign background. Further information about 





Additionally, two types of Control DNA, 2800M from the ForenSeq DNA Signature Prep kit 
and 007 from the AmpFLSTR NGM SElect PCR Amplification Kit (Applied Biosystems™, 
ThermoFisher Scientific), were used to test how little DNA is needed to still obtain a complete 




 DNA EXTRACTION 
 
DNA from most of the samples in the biobank were already extracted in 2016 using either the 
DNA DSP Midi kit on the QIAsymphony robot (Qiagen) or the PrepFiler Express Forensic 
DNA Extraction Kit on the AutoMate Express instrument (ThermoFisher Scientific) (38, 46). 
Because of extraction failure a few samples (n = 8) needed to be reextracted in this study. For 
this purpose, the QIAamp DNA investigator kit (Qiagen) with manual pipetting was used, 
following the manufacturer’s protocol (Qiagen, 2012) (66). This specific kit was chosen 
because DNA yields are known to be higher than with the PrepFiler Express kit. This is not so 
important for this study, but DNA extracts are also planned to be used in other projects later, 
requiring higher amounts of DNA. Furthermore, for so few samples it had not been profitable 
to use the QIAsymphony robot. 
DNA extraction is a process in which DNA is separated from other cellular components (1). 
The QIAamp DNA investigator kit is for isolating both genomic and mitochondrial total DNA 
from small volumes of whole blood. In addition to the process being efficient, the kit is also 
designed to reduce contamination between samples. The protocol for the QIAamp DNA 
investigator kit consist of four steps: 1. Lysing the cells with proteinase K and two different 
buffers, 2. Binding the DNA to the membrane in the QIAamp MinElute spin column by 
centrifugation, 3. Cleaning the DNA with ethanol and washing buffers in several steps, and 4. 
Eluding the DNA with an elution buffer. The result is DNA, which is free of nucleases, proteins 







 DNA QUANTIFICATION  
 
As previously mentioned, DNA from most of the biobank samples was already extracted and 
quantified (38, 46). Therefore, only a subset of biobank samples (n = 8) had to be re-quantified. 
Furthermore, dilutions of Control DNA used in the sensitivity study (n = 12) were quantified 
and checked if they contained the expected DNA-concentration. For further details of the 
sensitivity study see below.  
The amount of DNA in each sample was determined by using the DNA Quantifiler Trio DNA 
Quantification Kit (ThermoFisher Scientific) on the 7500 Fast Real-time PCR system (Applied 
Biosystems), following the manufacturer’s protocol (ThermoFisher Scientific) (67). The 
purpose of this step is to measure the amount of amplifiable human DNA in a sample so that 
the amount of DNA used in further analysis steps can be controlled.  All the biobank samples 
were diluted 1:20 before quantification to avoid concentrations outside the range of the standard 
curve. The standard curve is based on DNA dilutions with known concentrations run in 
duplicates. Samples between 0.005 and 50 ng/µl can be reliably quantified with this kit.  
Three different TaqMan probes, which are short sequences that bind to specific human target 
loci, are included in the reaction mix. The small and large autosomal targets (SA and LA) are 
both found in multiple copies on different autosomal chromosomes, and the Y-chromosome 
target (Y) is located on the Y-chromosome. The probe for the small autosomal DNA target is 
used to quantify the amount of amplifiable human DNA in a sample. Because large DNA 
fragments degrade first, the state of degradation in a sample can be measured by comparing the 
ratio between the small and large autosomal DNA fragments, given as degradation index (DI). 
The Y chromosome target is used to measure the amount of male DNA in a sample, which may 
be highly relevant for mixed samples.  The information on a sample’s DI and amount of male 
DNA were not further considered in this study. 
The quantification system also contains a synthetic internal PCR control (IPC) that detects if 
PCR inhibitors are present in a DNA sample. The IPC consists of a synthetic DNA template 
present in each sample and is less amplified in the presence of inhibitors. It can also provide 
confirmation that all assay components are functioning as expected. Thus, the IPC allows users 
to distinguish between negative sample results and samples that may be affected by the analysis 





In figure 9, a schematic drawing of the quantification method based on a 5’-nuclease assay is 
shown: 1) The TaqMan probes attach to their complementary sequences (target) between the 
forward and revers primer sites. They contain a specific fluorescent 5´- reporter and a non-
fluorescent 3´-quencher. As long as the probe is intact, the quencher and reporter are close 
enough for the quencher to absorb the light that the reporter is emitting. 2) Polymerization of 
the complementary DNA strand and strand displacement of the TaqMan probe starts. 3) During 
amplification of the target sequences, the Taq DNA polymerase enzyme cleaves the probe and 
separates the reporter from the Quencher. The result is a non-supressed reporter now able to 
emit light that can be measured. Taq DNA polymerase has 5’ to 3’ exonuclease activity, which 
means the nucleotides on the probe will be cleaved from the 5’end to the 3’ end. 4) The 
polymerization continues. However, because the 3’end of the probe is blocked, there is no 




Figure 9. Overview of the 5′ Nuclease assay. 1. The Tag DNA polymerase enzyme anneals to the forward primer 
and starts polymerization of the complementary DNA strand. 2. Strand displacement of the TaqMan probe begins. 
3. The polymerase cleaves the probe. Separation of the reporter and quencher increases the fluorescence signal. 






The fluorescent signal increases proportionally to the amount of DNA amplified in each sample. 
When reporters are cleaved from the TaqMan probe they emit a fluorescent signal. Naturally, 
the increase in amplified DNA is proportionate to the increase of the fluorescent signal. The 
strength of the fluorescent signal will at some point exceed a pre-defined threshold, and the 
sample’s fluorescence signal is compared to the standard curve. The number of PCR cycles the 
samples need to reach the fluorescence threshold is measured in a threshold cycle value (CT-
value). The quicker the sample reaches this CT-value, the higher the DNA concentration in the 
sample. The standard curve is based on samples with known concentrations between 0.005 and 
50 ng/µl. By using the standard curve, the amount of DNA in each sample can be read by 
knowing their CT-value. Figure 10 shows a standard curve plotted against the CT-value on the 



















 NORMALIZATION AND DILUTION 
 
In this step, the DNA in all the samples is normalized to 0.2 ng/µl, this is done to ensure the 
same DNA amount in each sample when the library is being made. Using the quantification 
results, the biobank samples were normalized by diluting them with TE-buffer (10 mM Tris-
HCl, 0.1 mM EDTA, pH 8.0) to a concentration of 0.2 ng/µl DNA. 5 µl of each sample is added 
to the library to have a final DNA amount of 1 ng, which is the recommended input amount for 
gDNA for the Signature Prep kit.  
For the sensitivity study, two types of Control DNA were used to make a series of 6 dilutions 
with a factor two. The two types of Control DNA were 2800M and 007, from the ForenSeq 
DNA Signature Prep kit the AmpFLSTR NGM SElect PCR Amplification Kit, respectively. 
Using the DNA concentration provided by the manufacturers as a starting point, the samples 
were diluted with TE-buffer (10 mM Tris-HCl, 0.1 mM EDTA, pH 8.0). This was done in triplet 
series to reach the concentrations given in table 3. 2800M and 007 had different starting 
concentrations. Therefore, the 007 dilution series started at 500 pg and the 2800M dilution 
series started at 1000 pg. To be able to compare the sequencing and quantification result the 
triplet DNA samples were marked with numbers from 1-7 to reflect their position in the dilution 
series. The sample were quantified to ensure that the dilutions was done accurately. All 
normalized and diluted samples were stored in the fridge (~4°C) until library preparation was 













Table 3. Amount of Control DNA for the libraries prepared for the sensitivity study. Control DNA 2800M from 
the ForenSeq DNA Signature Prep kit and 007 from the AmpFLSTR™ NGM Select™ PCR Amplification Kit were 
diluted with TE-Buffer. By using the manufacturer’s stated DNA concertation, the dilution series was calculated 
so that 5 microliters of each sample into the library would result in the DNA concentration as stated in the table. 
All dilutions were prepared in triplets. 
 
Control DNA 007 DNA Amount Control DNA 2800M 
- 1000 pg 1-2008M 
2-007 500 pg 2-2008M 
3-007 250 pg 3-2008M 
4-007 125 pg 4-2008M 
5-007 62.5 pg 5-2008M 
6-007 31.25 pg 6-2008M 
7-007 15.625 pg - 
 
  
 LIBRARY PREPARATION, FORENSEQ DNA SIGNATURE PREP KIT: 
 
All the libraries were prepared by using the ForenSeq DNA Signature Prep kit, following the 
manufacturer’s protocol with minor exceptions (Illumina, 2015) (69).  Samples were all diluted 
with TE-buffer and not nuclease free water as stated in the protocol.  
When working with the beads, several steps were taken to ensure that they were well mixed 
when in use. For example, they were never centrifuged after vortexing. The beads were also 
vortexed regularly in-between pipetting steps. The largest available pipette tips was always used 
to ensure an even distribution of beads, although volumes were so small to allow for smaller 
tips. These three steps were taken in order to inhibit the beads sinking to the bottom of the tube 
and prevent uneven distribution of beads to each sample. This was done during library 
purification and normalization. Each setup usually contained 30 samples in addition to two 
controls, according to the manufacturer’s recommendation for samples of good quality in 





For the sensitivity study, the dilution series of different control DNAs (2800M and 007) were 
prepped and sequenced in separate setups that were filled up with biobank samples to reach the 
maximum of 32 reactions.  
Library preparation consists of various steps shown in Figure 11: Amplifying and tagging the 
target sequences, enriching the targets, purifying libraries, normalizing and pooling the 
libraries, and finally diluting and denaturing the pooled libraries. The DNA sample is mixed 
with tagged oligos that are linked to copies of the targets by PCR. This forms DNA templates 
with the regions of interest flanked by universal primer sequences. Index adapters are then 
attached to the tags and amplified with another PCR. Thereafter, the library is purified, 
normalized and pooled and is ready to be sequenced.  
 
 
Figure 11. Overview of the Library Prep workflow using the ForenSeq DNA Signature Prep kit. Modified from 







2.5.1 AMPLIFY AND TAG TARGETS, PCR1 
In this step, the genomic DNA in the samples are amplified and tagged using the ForenSeq 
oligonucleotide primer mix (Illumina). The primer mix is specific to different DNA sequences 
up- and downstream of STR and SNP markers included in the kit. Two different DNA primer 
mixes, DPMA and DPMB are included in the kit. Only DPMB is used in this study, including 
primers for 58 STRs (including 27 autosomal STRs, 7 X and 24 Y STRs), 94 identity-
informative SNPs, 56 ancestry-informative SNPs and 22 phenotype-informative SNPs. Thus, 
results for a range of different markers can be obtained in one analysis.  
All the DNA samples were vortexed and spun down before use. The master mix was made by 
pipetting PCR1 reaction mix, FEM enzyme mix, and DPMB together, according to protocol. 
10 µl of the master mix was added to each of the 32 wells in a MicroAmp Optical 96-Well 
Reaction Plate (Applied Biosystems), then 5 µl of the normalized human DNA samples was 
added to their respective wells. A positive control (2800M) and negative control was also used 
in each setup. The plate was then sealed and spun down before placing it on the Veriti™ 
Thermal Cycler (Applied Biosystems, ThermoFisher Scientific) for the first PCR (PCR1). The 
cycling conditions were set according to the manufacturer’s protocol for a 9700 thermal cycler 
in 9600 emulation mode (70). PCR1 lasts for about 3.5 hours. The PCR1 program entails: 98°C 
for 3 min, 8 cycles of: 96°C for 45s, 80°C for 30s, 54°C for 2 min with specified ramping mode 
(8%) , 68°C for 2 min also with specified ramping mode, 10 cycles of: 96°C for 30s, 68°C for 




2.5.2 TARGET ENRICHMENT, PCR2 
In this step, the DNA is amplified, and sequences required for cluster amplification are added. 
Index adapters 1 (i7) and 2 (i5) are added giving each sample a unique combination of index 
adapters. This is necessary for the sequencing system to be able to separate the data from 
different samples in the library after being pooled together. The ForenSeq DNA Signature Prep 
kit includes eight different index adapters 2 and twelve different index adapters 1. Because each 
setup consists of 32 samples including controls, only four of the twelve different index adapters 
1 are used at a time. To prevent any contamination between runs, the use of the same four index 






After PCR1 was finished, 4 µl of index 1 and 2 were added to each well according to the sample 
sheet. 27 µl of PCR2 reaction mix was then added to the wells, and the plate was sealed again 
and placed on the Veriti™ Thermal Cycler for the second PCR (PCR2). The cycling condition 
were set according to the manufacturer’s protocol for a 9700 thermal cycler in 9600 emulation 
mode (70). The PCR2 program entails: 98°C for 30 seconds, 15 cycles of: 98°C for 20s, 66°C 
for 30s, 68°C for 90s, then 68°C for 10 minutes and a final hold at 10°C (69). When working 
with the index adapters it is important to prevent cross contamination between them. Therefore, 
gloves were changed frequently, and the index tubes were sealed with fresh caps each time after 
used.  
 
2.5.3 PURIFY LIBRARIES 
After PCR2, the libraries were purified using Sample Purification Beads (SPB). The goal is to 
separate the amplified DNA from the PCR reaction components, such as unbound adapters. 
When using SPB it is important to mix the solution thoroughly by vortexing and pipetting up 
and down . This is to insure an even distribution of the beads added. A magnetic stand was used 
to trap the amplified DNA between the magnetic beads. These form a pellet as long as the 
reaction plate is placed on the magnet. The pellet was then washed twice with freshly prepared 
80% ethanol before the amplified DNA was resuspended from the beads using a resuspension 
buffer (RSB). The purified libraries were now ready to be normalized.  
 
2.5.4 QUBIT® DSDNA HS ASSAY 
Before normalization of the libraries, the amount of DNA in each sample was quantified with 
the Qubit® dsDNA HS (High Sensitivity) Assay Kit  following the manufacturer’s protocol for 
the Qubit® 2.0 Fluorometer (Invitrogen, ThermoFisher Scientific, revision B.0)  (71). The 
samples were quantified in order to determine if every step has worked as expected to this point. 
In addition, the Qubit measurements give an indication of how well the sample may perform 
under sequencing.  
The kit contains a dilution buffer, two DNA standards and an assay reagent. A master mix was 





tubes that contained a final volume of 200 µl after adding 2 µl of DNA sample or 10 µl of 
standard.  
First, the two standard tubes were read to create a standard curve that the DNA samples could 
be measured against. Then, the sample tubes were placed into the Qubit® Fluorometer and read 
by measuring the emitted fluorescence light from fluorophores attached to the dsDNA in the 
sample.  The instrument measures the concentration of the sample after it is diluted in the assay 
tube. Therefore, the actual concentration needs to be calculated using the following equation:  
Concentration of the sample (ng/µl) = QF value * (200/volume of sample added) 
The QF value is the value given by the Qubit® 2.0 Fluorometer. The volume of sample added 
to the assay tube in this study was always 2 µl.  
 
2.5.5 NORMALIZE LIBRARIES 
 
The normalization process prepares for cluster generation by normalizing the DNA 
concentrations among samples so that they are equally represented in the sequencing run. This 
step is necessary to achieve a pooled library with the same amount of DNA from each sample. 
By doing this, the samples can achieve consistent cluster density to optimize the resolution of 
the individual samples when pooled together.  
 
First, a master mix is made of Library Normalization Additives 1 (LNA1) and Library 
Normalization Beads 1 (LNB1). Here it is important to remember that the LNB1 has to be 
vortexed thoroughly in order to have an even distribution of the beads in the master mix. 20 µl 
of the purified library were added to the master mix and shaken on a BioShake XP (Quantifoil 
Instruments GmbH) for 30 minutes. The library was then washes twice with Library 
Normalization Wash buffer 1 (LNW1) before 0.1 N HP3 was added and mixed well. HP3 was 
added to break the hydrogen bonds between DNA bases, converting a DNA strand from double-
stranded to single-stranded molecules. However, it is important to work fast after adding the 
HP3, because otherwise the DNA will start to degrade. Lastly, the Library Normalization 






2.5.6 POOL, DILUTE AND DENATURE LIBRARIES  
In this step, the normalized libraries were pooled together in a single tube, adding 5 µl of each 
sample. The pooled samples were sequenced together on the same flow cell. Finally, the pooled 
library was diluted with the Hybridization Buffer (HT1) provided in the MiSeqFGx Reagent 
kit, and 2 µl of Human Sequencing Control (HSC) was added, making a total of 600 µl. The 
HSC is a DNA library of 23 ForenSeq STRs functioning as a positive sequencing control (48).   
 
According to the manufacturer, it is recommended to use 7 µl of pooled library in the final 
dilution. Based on previous experience with this kit, 14 µl of pooled library was used for most 
of the sequencing runs (46). However, for a few runs, only 10 or 12 µl of pooled library was 
used to avoid over clustering of the flow cell.  The decision was based on higher than usual 
Qubit values of the purified libraries that may be caused by variation between lots.  
 
When denaturing the diluted pooled library, it was heated for exactly 2 minutes, then 




 MISEQ SEQUENCING, MISEQ FGX REAGENT KIT:   
 
Developed in collaboration with the forensic community, Illumina created the MiSeq FGx™ 
Forensic Genomics System, which is the first fully validated NGS system specifically designed 
for forensic genomics applications. The MiSeq FGx system enables users to analyse forensic 
DNA samples from DNA-to-data. The system contains the UAS, which can analyse STR and 
SNPs for human identification. A major advantage of NGS in forensic genomics is the ability 
to analyse and separate alleles that are identical in size, but different by sequence. This provides 
an important and precise method for human identification. 
The software enables run setup, sample management, analysis, report generation as well as 
mixed DNA sample detection. The software also provides several features not relevant for this 
study, such as population statistics, automated sample comparison as well as an estimation of a 





Following the instructions in the MiSeq FGx Instrument Reference Guide (73), the flow cell 
was thoroughly washed, and the reagent cartridge was loaded with the denatured diluted pooled 
library. Each sequencing run takes approximately 30 hours, containing 398 cycles. A total of 
16 sequencing runs were conducted with the 17 prepared library set ups, including some reruns 
due to human and machine errors.  
The Illumina sequencing workflow consist of four steps, sample preparation (explained above), 
cluster generation, sequencing and data analysis (74).   
 
2.6.1 CLUSTER GENERATION 
Cluster generation occurs on the flow cell, which is a glass slide with lanes. Each lane is a 
channel with a lawn coated with two types of oligos. When the library samples run through the 
flow cell, hybridization occurs randomly between the DNA fragment adapters in the sample 
fragments and the complementary oligos attached to the flow cells. Then, a polymerase creates 
a complimentary copy of the original template strand. This is the first step in cluster generation. 
The double stranded molecule is then denatured, and the template is washed away as it is not 
covalently bound to the adapter sequence on the flow cell. Clusters are generated by a process 
called bridge amplification. The strands are clonally amplified by folding over, and the adapter 
region hybridizes to the second type of oligo on the flow cell. Polymerases elongate the second 
oligo by generating a complementary strand, thus forming a double stranded bridge. The two 
copies are denatured resulting in two single stranded copies of the molecule that are covalently 
bound to the flow cell on each their oligo. This bridge amplification process happens 
simultaneously for millions of clusters and is repeated. After bridge amplification, all the 
reverse strands are cleaved and washed away, leaving only the forward strands that have their 
3’ end blocked to prevent any unwanted priming. Figure 12 shows an overview of the basic 







Figure 12. Overview of cluster generation steps. 1. The original DNA template is used to make a complementary 
template copy. 2. Bridge amplification where the template copy flips over and hybridizes to the neighbouring 
complementary oligo, creating a bridge. 3. The template is copied creating a double stranded bridge. 4. The bridge 
is denatured. 5. The sequence primers hybridize, making the samples ready for sequencing. Modified from: (75).  
 
2.6.2  SEQUENCING 
 
The sequencing technology applied by Illumina involves a process called Sequencing by 
Synthesis (SBS), using fluorescently labelled dNTPs with a reversibly terminated end that are 
sequentially added by a DNA polymerase. The individual dNTPs carry a specific fluorophore 
that helps the software to identify each base added during sequencing.  Sequencing begins with 
the extension of the first sequencing primer to produce the first read. With each cycle, all the 
four nucleotides compete to be added to the growing chain, but only one of them will match 
based on the complementary nucleotide in the template strand. After the nucleotide is added the 
others are washed away. The clusters are excited by a light source, and their specific florescence 
is emitted. The number of cycles determines the length of the read whilst the emitted 
wavelength and signal intensity determine the base call.  The fluorophore and terminated ends 
on the dNTPs are cleaved and washed away, enabling the addition of a new nucleotide in the 
following sequencing cycle.  
After the first read, the read product is washed away. In this step, the index 1 read primer is 
introduced and hybridized to the template, and the read is generated similar to the first read. 
After completion of the index read the product is washed away. The 3’ ends of the template are 
unblocked, and the template fragment folds over and binds to the second type oligo attached to 
the flow cell, creating a bridge. Index 2 is read in the same manner as index 1. The polymerase 
extends the second oligo forming another double stranded bride.  The double stranded bridge 





away, leaving only the reverse strand. The second read begins with the introduction of the read 
2 sequencing primer. The sequencing steps are repeated as in read 1 until the desired read length 
is achieved. This process generates millions of reads that represent all the sequenced fragments.  
Finally, the sequences from the pooled sample libraries are separated based on the unique 
indexes introduced during the sample preparation. For each sample, reads with similar stretches 
of base calls are locally clustered. Forward and revers reads are paired to make a contiguous 
sequence, which are then aligned back to the reference genome by the software (47, 74, 76, 77).  
  
2.6.3  DATA ANALYSIS  
 
Before running the MiSeq FGx instrument, a file containing the names and different index 
combinations for each sample for the particular run was uploaded onto the server and 
transferred to the instrument. After the run  had finished, the data was automatically analysed 
with the ForenSeq Universal Analysis Software (78). The software is specifically developed for 
analyses of data obtained with the ForenSeq DNA Signature Prep Kit. It is installed on a stand-
alone server, and the data is viewed through a web browser (Google Chrome).  
After a sequencing run, the results were evaluated. When first looking at the overall quality of 
the two control samples and quality metrics, they would either be marked with green, orange 
or black. Green indicates that all metrics are within the acceptable range set by the 
manufacturer. Orange indicates that at least one metric is not within the acceptable range. Black 
indicated that no metrics are assessed with the analysis. The quality metrics include cluster 
density, clusters passing filter, phasing, pre-phasing, number of reads and index quality.  
Cluster density (K/mm²) is the number of clusters per square millimetre on the flow cell for the 
run. The recommended target cluster density range is between 400– 1650 K/mm². Clusters 
Passing Filter (%) is the percentage of all clusters that pass the Illumina chastity filter, which 
measures quality. Data only appears after cycle 25, and the filter detects low quality base calls. 
The recommended cluster passing filter is a above 80%. However, cluster density and cluster 
passing filter values that are outside of the recommended range can still produce results that are 
sufficient for analysis. 
During the sequencing reaction, each DNA strand in a cluster is extended by 1 base per cycle. 





running a base ahead (pre-phasing). Phasing and pre-phasing estimates the fraction of 
molecules that became phased or pre-phased in each cycle within Read 1 and Read 2. Low 
percentages indicate good run statistics. The recommended phasing and pre-phasing values are 
≤ 0.25% and ≤ 0.15%, respectively. 
A check list was made, containing different criteria that had to be met in order for each sample 
to be considered as a complete DNA profile (see Appendix I). For example, if an allele was 10-
15% of the alternate allele’s size, and in stutter position, it was considered a stutter. A stutter is 
a PCR artefact, which is produced when the DNA polymerase slips and creates a minor product 
band which is smaller than the main fragment (usually 4bp shorter) (79). After all the 
checkpoints were run though, a sample was re-sequenced if it did not have a complete STR or 
SNP profile, i.e. there were any drop outs or if it was uncertain if a marker was homozygous or 
heterozygous, i.e. there was one allele call that was below the interpretation threshold. The goal 
was to achieve complete profiles for all the markers even though only results for the autosomal 
STR markers were considered further in this study. It should also be mentioned that all 
thresholds pre-set by Illumina were used, such as the analytical threshold, interpretation 
threshold and stutter filter. 
Further assessment of the sequencing result included the comparison of two reagent lots, 
checking the reproducibility of the kit as well as the concordance between the Signature Prep 
and NGM Select kit. As previously mentioned, several lots of the Signature Prep kit were used 
during this study. Based on previous experiences (38, 46) there could be lot to lot differences. 
Therefore, the run metrics and marker performance of two representative runs from each of two 
different reagent lots was compared. Marker performance included, STR coverage, allele 
balance within each STR, markers flagged for imbalance by the UAS and stutters which had to 
be manually removed because the UAS called them as alleles. The average coverage of each 
STR was plotted in Excel and standard deviations were calculated using the STDAV formula 
within the Excel program. Allele balance was calculated by dividing the allele with the lowest 
amount of reads with the highest. If the software calculates an intralocus balance below its 
predefined threshold, the imbalance quality control indicator is triggered. The allele balance 
was also plotted in Excel with their corresponding standard deviation values. The UAS 
generates a file containing sequencing information of all the samples run, including if any 
marker has been flagged for imbalance. By going through this file, all the STR markers flagged 
for imbalance could be identified. Lastly, all sample were correlated after sequencing. and the 





Because many samples were re-sequenced during this study, there were several parallel 
sequencing results available for a range of individuals. This data was used to compare the STR 
results and check the reproducibility of the MiSeq FGx Forensic Genomic System. The samples 
run more than once were checked for each marker, and any discrepancies where noted and 
evaluated. To be included in the comparison, the overall sequencing run had to be good, and 
samples had to have more than 85000 reads. Lastly, the concordance of STR-genotypes in the 
15 overlapping markers between the two kits were evaluated. The NGM SElect genotype data 
was already available at the Centre of Forensic Genetics.  
The dataset was analysed using STR Analysis for Forensics (STRAF), an online tool that 
performs forensics and population genetics analysis of STR data, to obtain the length-based 
allele frequencies for the Norwegian population sample. In addition, population genetic 
parameters were also obtained, such as Genetic Diversity (GD) and Polymorphism Information 
Content (PIC, the probability of being able to assume which allele a parent has passed on to the 
child),  Match Probability (PM, the probability of a match between two unrelated individuals), 
The Power of Discrimination (PD, the probability to discriminate between two unrelated 
individuals), The power of exclusion (PE) and the Typical Paternity Index (TPI), which reflects 
the mean allele frequency for random non-excluded men at a given locus (80).   
A Principal Component Analysis (PCA) module is also included in the STRAF-tool. PCA is 
used to control the population substructure and quality. The PCA detects genotype clusters 
caused by population substructure (81). A single cluster on the PCA is normally expected for 
forensic population studies based on STR data. The single cluster expectation can also serve as 
a quality control of the data. If outliers are identified on the PCA plot, a check of these samples 
is warranted (80). 
The dataset can also be tested for Hardy-Weinberg Equilibrium (HWE) and Linkage 
Equilibrium (LE) with the STRAF-tool. HWE is used to check if alleles within a locus are 
independent, while LE is used to check if loci are independent. These two tests are usually used 
when establishing a new population database. 
The HWE can calculate genetic variation of a population at equilibrium. The HWE equation is 
based on the Hardy-Weinberg equilibrium, which states that the amount of genetic variation 
found in a population will remain constant between generations if no disturbing factors such as 
no net mutation, natural selection or migration occur. Further assumptions of the model are 





frequencies in a population will remain unchanged over following generations, and the 
population is in Hardy-Weinberg equilibrium. The model can be applied to the genotype 
frequency of a single gene.  
The Hardy-Weinberg model for a marker with two alleles p and q entails two equations: one 
that calculates allele frequencies (p + q = 1), and the other that calculates expected genotype 
frequencies (p2 + 2pq + q2 = 1). So, if p and q allele frequencies are known or measured in a 
population, then the three expected genotype frequencies p2, 2pq and q2 can be calculated using 
the Hardy-Weinberg equation (1, 30). A marker is in HWE if the observed and expected 
genotype frequencies are not significantly different. For STR markers it is more complicated to 
calculate HWE because there are more than two possible alleles for each marker.  
Allele frequencies can be calculated based on the observed genotype frequencies in the DNA 
profile data set of the Norwegian population. Then, the allele frequencies are used to calculate 
the expected genotype frequencies. The observed and expected genotype frequencies are 
compared in the HWE test. If they differ from one another, then there is a deviation from HWE, 
which means that some genotypes are more common than expected. The reason why could be 
natural selection, mutation or migration within the population tested.   
Linkage equilibrium (LD) is a term used for two genes/ loci that are inherited independently in 
each generation, for example, two STR loci that are in random association and are originally 
located on two different chromosomes. In contrast, if two genes are in linkage disequilibrium, 
certain alleles from each gene are inherited together more often that they would be by chance. 
The genes can be closely located on the same chromosome. Alternatively, linkage 
disequilibrium could be caused by an interaction between combinations of alleles at the two 
loci affecting viability of potential offspring (82). 
To ensure that an allele is reliable in statistical calculations of the evidential weight, a minimum 
allele frequency is used for rare alleles. The minimum allele frequency is 5/2N, where N is the 
number of individuals sampled from the population. Allele frequencies can be inaccurate if the 
allele is so rare that it is represented only a few times in the database. Some alleles might be so 
rare that they are not represented in the database at all. Each allele is recommended to at least 
be observed 5 times before it can be included in the database. However, for rarer alleles, the 
frequency is adjusted to the minimum frequency (1).   
After determining the length based allele frequencies using STRAF, the sequence based 





2018 (52, 53, 83, 84). The allele frequencies along with their corresponding sequence is listed 
in Appendix IV. Some of the markers had a flanking region next to the sequence 
characterized, these are written in a light colour, and include D13S317, D18S51, D19S433, 




3 RESULTS  
 
During this study, a total of 287 individuals were sequenced. Some of them had to be re-
sequenced. In total, 16 library setups were prepared, each containing 30 samples plus controls. 
One of the goals of this study was to sequence all of the 540 individuals in the research biobank 
to build a population database for allele frequencies of autosomal STR-markers. After 
correlating the samples, complete data for all the autosomal, X- and Y-STRs was obtained for 
most of the samples. However, for 20 samples there are still some SNPs that yielded 
inconclusive or no results. These SNPs are known to be difficult to type, considering their low 
number of reads. These samples will be re-sequenced at a later stage.    
Since a significant quantity of samples was sequenced more than once, there was a good 
opportunity to compare their respective results to each other and evaluate the reproducibility of 
the MiSeq FGx Forensic Genomic System. Of the 287 individuals sequenced during this study, 
263 (91.6%) were sequenced more than once. There were no deviations in autosomal STR 




 PERFORMANCE OF THE FORENSEQ DNA SIGNATURE PREP KIT  
 
Lot performance of the ForenSeq DNA Signature Prep kit was done with data from two 





chosen, and the sequencing of these runs was performed under the same conditions and 
according to the protocol. 1 ng DNA was amplified with DPMB from the ForenSeq DNA 
Signature Prep kit. All samples were quantified with the Qubit dsDNA HS Assay (Qiagen). 14 
µl of pooled library was used for all four sequencing runs.  
First, some of the run metrics of the two lots were compared (table X). The optimal cluster 
density range is expected to be between 400-1650 K/mm2. From the four runs, a cluster density 
between approximately 1100 and 1500 K/mm2 was obtained, which is well within the set 
parameters set by the manufacturer (73) and also the expected range based on earlier run 
experience.  
Qubit measurement of the samples was done to determine the DNA concentration in each 
sample after library purification to indicate how well the sample had performed so far. The 
average DNA quantity after purification is relatively similar between lots, ranging from 5.7 to 
7.15 ng/µl with overlapping standard deviations (table x). The sample coverage ranged between 
100 000 and 672 000 reads, except for one sample from run X which had less than 85 000 reads. 
There was no obvious difference in the average sample coverage between lots (table 4). The 
index CV indicates how even the number of reads are between the samples. The index CV 
ranged from between 32.5 and 43.7 %.   
 
Table 4. Performance of two different lots of the ForenSeq DNA Signature Prep kit. 
  Lot 1 (RGT8232152)  Lot 2 (RGT 1518597) 
DNA-quantity of purified 
libraries (ng/µl) - Qubit 
2.1 – 12.1 0.48 – 13.6 
Average Qubit quantity 
(ng/µl) 
7 ± 3.07 7.15 ± 3.26 6.49 ± 0.96 5.47 ± 2.33 
Run number 1 2 3 4 
Cluster density K/mm2 1163 1201 1532 1185 
Index CV (%) 36.5 43.7 32.5 38.1 
Average # Reads  287633 ± 89387 350517 ± 123332 480200 ± 127644 383571 ± 107138 






STR marker performance was evaluated, including aspects such as locus coverage, allele 
balance within markers, markers flagged for imbalances and stutters not removed by the stutter 
filter in the UAS.  
The average number of reads varies greatly between markers. Most of the STR markers have 
an average allele balance close to 0.8, with variable standard deviations (Fig. 13). STR-markers 
D1S1656, D5S818 and D22S1045 have slightly lower allele balances. Their average allele 
balance for lot 1 and 2 was respectively 0.78, 0.73, 0.61 and 0.55, 0.56, 0.61. STR-markers 
D1S1656 and D5S818, and also D19S433 have higher standard deviations than the other 
markers. This means the alleles are more variable, which could indicate that they are more 
variable than the other markers. Sometimes they may be good, but other times they yield bad 
results. In general, there is not a big difference between the two lots, but for D1S1656 and 
D5S818 the allele balance was even poorer in lot 2 than in lot 1. Table 5 shows an overview of 
the markers flagged for allele imbalance by the UAS, using predefined thresholds by Illumina. 
The markers flagged most often for imbalance were D1S1656, D5S818 and D22S1045 (n>30). 
There is a clear correlation between markers with most imbalance flags and markers with low 
allele balance (Fig.13). There were more imbalances observed in lot 1than in lot 2.  
The marker with the lowest average amount of reads for lot 1 is vWA and D19 for lot 2. The 
marker with the highest average amount of reads from lot 1 is D20S482 and TH01 for lot 2.  In 
addition to this, the standard deviation for markers such as TH01 and D6S1043 are quite large 









Figure 13. A: The average #reads ± standard deviation for each STR marker. B: The average allele balance of 
STR markers ± standard deviation. 
 
 
Table 5. All STR markers flagged for imbalance by the UAS filter.  
Marker 
LOT 1: flagged for 
imbalance 
LOT 2: flagged for 
imbalance 
Total flagged per 
marker 
D1S1656 4 29 33 
D5S818   13 18 31 
D22S1045 17 13 30 
PentaE  5 10 15 





vWA 4 5 9 
PentaD 3 3 6 
D12S391 3 2 5 
D19S433 4 1 5 
D7S820 1 4 5 
CSF1PO 2 2 4 
D6S1043 2 1 3 
TPOX 2 1 3 
D10S1043 1 1 2 
D16S539 2 0 2 
D17S1301  2 2 
D2S1338 1 1 2 
D8S1179 1 1 2 
FGA 0 2 2 
D10S1248 1 0 1 
D21S11 0 1 1 
D4S2408 0 1 1 
D9S1122 0 1 1 
TH01 0 1 1 
Total 72 103  
 
 
Table 6 shows the number of stutters that were not filtered away by the UAS and had to be 
manually removed from the DNA profile. For lot 1, the markers with most unfiltered stutters 
were D6S1043, D17S1301, D22S1045, D9S1122 and D18S51. For lot 2, the markers with most 
unfiltered stutters were D19S433 and D20S482.  
 
Table 6.  Number of stutters that were manually removed because they were not filtered away by the UAS.  
Marker 
 
Lot 1 Lot 2 
Total 
per marker 
D6S1043 4 2 6 
D17S1301 3 2 5 
D22S1045 3 1 4 
D9S1122 3 1 4 
D18S51 3  3 
D19S433 2 4 6 
D20S482 1 3 4 
D21S11 1  1 
D7S820 1  1 
vWA 1  1 





D2S1338  1 1 
Penta E  1 1 




 CONCORDANCE BETWEEN THE SIGNATURE PREP AND THE NGM SELECT KIT 
(THERMOFISHER SCIENTIFIC) 
 
Concordance between the Signature Prep kit and the NGM SElect kit from ThermoFisher 
Scientific (CE based method) a method used by FGC, was checked to establish if two kits with 
different methods could produce the same autosomal genotype results.  
The STR markers analysed in these kits vary, so only the 15 overlapping markers could be 
considered. The 15 markers used were: D10S1248, D12S391, D16S539, D18S51, D19S433, 
D1S1656, D21S11, D22S1045, D2S1338, D2S441, D3S1358, D8S1179, FGA, TH01 and 
vWA. The genotype results from NGM SElect were previously obtained from the same biobank 
samples by FGC (unpublished data). The comparison of genotypes obtained with the Signature 
Prep kit and genotypes obtained with the NGM SElect Express kit showed three discordances. 
After comparing 32400 alleles using the NGM SElect and the Signature Prep kits (2 kits × 15 
loci × 2 alleles/locus × 540 samples), genotype concordance was found in 99.99% (32397 out 
of 32400) of the STR alleles compared. Discordance was found in in three different individuals 
and in a total of two different markers (see table 7). 
Sample 1 showed a discordance in marker D22S1045. When using the Signature Prep kit, allele 
11 (>7000 reads) was typed instead of allele 19 which was typed with the NGM Select kit. 
Allele 19 was however, present with (with 95 reads) but was not called by UAS and went 
unnoticed as a possible artefact instead of an allele. Sample 2 showed a discordance in marker 
D1S1656 where allele 13 (with 360 reads) was typed with Signature and allele 12 was typed 
with the NGM SElect. In this case as well, allele 12 was present (50 reads, stutter position) but 
was not called by the UAS. Lastly, sample 3 showed a discordance in D22S1045 where allele 
8 (with 11000 reads) was typed with Signature and allele 12 was typed with NGM SElect. In 






Table 7. Genotype concordance between the Signature Prep and NGM SElect kit. The three individuals listed 
showed discrepancies. Sample 1 showed discordance in D22S1045, allele 11 was typed with Signature Prep in 
contrast to NGM Select typing allele 19. Sample 2 showed discordance in D1S1656, the Signature Prep kit typed 
allele 13 compared to allele 12 typed with NGM Select kit. And lastly, sample 3 showed discordance in D22S1045, 
allele 8 was typed with Signature Prep and allele 12 was typed with the NGM Select kit.  













 POPULATION DATABASE 
 
The length-based alleles obtained from the biobank where analysed with the computer 
programme STR Analysis for Forensics (STRAF). This was done to obtain the autosomal STR 
allele frequencies for the Norwegian population, to perform various population genetic analysis.  
With STRAF analysis the autosomal STR allele frequencies were calculated based on the 
length-based allele frequencies (see figure 14) was obtained. The average number of alleles per 
marker is 11.3. The markers with the highest number of length-based allele variants are FGA 
(19 alleles), D18S51 (18 alleles) and D1S1656 (18 alleles). The markers with the lowest number 
of length-based allele variants are D4S2408 (5 alleles), TPOX (7 alleles) and TH01 (7 alleles) 
(Fig. 14). The data file containing the allele frequencies used for this figure can be found in 







Figure 14. Plot distribution of LB-allele frequencies per each STR-locus calculated using STRAF. 
 
Different forensic parameters for the Norwegian population were calculated using STRAF. The 
results (see table 8) for each marker includes values for; Expected Heterozygosity/ Genetic 
diversity (GD), Polymorphism Information Content (PIC), match probability (PM), power of 
discrimination (PD), Observed Heterozygosity (Hobs), power of exclusion (PE), the typical 
paternity index (TPI) and p-value of the Hardy-Weinberg equilibrium (pHW).  
pHW is calculated using the expected and observed heterozygosity values. PentaD, vWA and 
D21S11 are the only three markers which have a pHW value <0.05, which means they are not 













A heat map of pairwise LD values shows that most of the loci are independent of each other 
(see figure 15). Values under 0.05 are significant, which means they are in linkage 
disequilibrium (53). The lowest values are shown in a darker colour in the heat map, for 
example FGA, TPOX and FGA, PentaD both have a p-value of 0.0. A matrix with pairwise p-
values is available in Appendix II. The PCA projection (see figure 16) obtained by STRAF 
yielded a plot based on the populations length-based alleles. It shows that the individuals in the 









Figure 15. Pairwise Linkage Disequilibrium p-values matrix plotted in a heat map. The darker the colour the 








Figure 16. PCA projection of Norwegian populations length based alleles obtained by STRAF. All the sequenced 
(length-based  allele) samples are plotted in a graph, showing two outliers, marked 1 and 2. Both these individuals, 
had upon further examination, African heritage.  
 
 
 SEQUENCE VARIATION  
 
Characterization of the sequence-based alleles lead to multiple novel alleles being observed. 
Markers such as CSF1PO, D18S51, D22S1045, D16S539, D17S1301 and especially D21S11 
showed an increase in sequence variants. D211S11 was the marker with the highest sequence 
variation with  
The sequence based allele frequencies showed many rare alleles (1 out of 1080 allele copies) 
in the Norwegian population. Some of the rare alleles obtained are found in markers: CSF1PO, 
D13S317 and All of the sequence-based allele frequencies are listed in Appendix IV, next to its 
corresponding sequence. The novel alleles found in this study are marked red in Appendix., 
Unfortunately, because of time restraint, not all markers where checked to see if there were any 
novel alleles. These markers include, FGA, D12, D19 and vWa.   










The number of individual alleles obtained by length and sequence were compared, see figure 
17. This was done to determine if some markers may become more informative by sequencing 
compared to length based. Eight of the twenty-seven autosomal STRs (TH01, TPOX, 
D10S1248, D20S482, D7S820, Penta D, Penta E and FGA) did not show an increase of alleles 
between the two methods (see figure 17). However, there are several markers that double, and 
even triple, their number of alleles obtained by a sequence based separation method compared 
to length based methods. These markers include; D13S317, vWA, D3S1358, D8S1179, 
D2S1338 and D21S11. The most polymorphic marker in this study is D12S391, the number of 








Figur 17. Allele increase for 27 autosomal STR markers targeted by the ForenSeq™ kit when comparing 
sequence-based to length-based alleles. The number of alleles obtained by length based separation methods are 
shown as the blue pole. Whilst the orange pole above represents the additional alleles obtained by sequence based 
separation methods.   
  
 
 SENSITIVITY STUDY 
 
For the sensitivity study two control DNA, 2800M and 007, were chosen to make the dilutions. 
The samples were also quantified, to ensure that they contained the correct concentration before 
library preparation and sequencing. Table 9, shows the quantified and measured DNA 
concentration compared to the intended concentration (Dilution). All the DNA concentrations 
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measured are approximately the same as the intended dilution. With small DNA concentrations, 
manually pipetting can affect the outcome considerably. This makes it very easy for the 
dilutions to vary and become a little more uneven than intended.  
 
Table 9. Control DNA samples, 2800M and 007, with intended dilutions beside the quantified DNA concentration.  
Control DNA 007 
 







Concentration (ng/µl) Sample Name 
    0.2 0.238 1-2008M 
2-007 0.152 0.1 0.125 2-2008M 
3-007 0.077 0.05 0.0542 3-2008M 
4-007 0.0301 0.025 0.0321 4-2008M 
5-007 0.0199 0.0125 0.0191 5-2008M 
6-007 0.0101 0.00625 0.009 6-2008M 
7-007 0.0036 0.003125     
 
 
The sample coverage is visualized in figure 18. All the samples were sequenced in triplets to 
ensure more reliable results. There is a clear parallel between the DNA concentrations and the 
sequencing coverage. The decrease in coverage is gradual as the concentrations gets lower, but 
it is not halved as one would expect when the concentration is halved. At each dilution step 
when the DNA concentration is lowered with 50%, the sample coverage only drops with 







Figure 18. Average sample #read (coverage) for control DNA samples analysed with the MiSeq FGx Forensic 
Genomic System. Six steps of triplet dilutions of control DNA 2800M and 007 were used, ranging from 1 ng to 
15.6 pg.  However, the two control DNAs had different starting concentrations in the dilution series.  
 
Apart from the system being able to read the samples with low concentrations, it was also 
important to examine whether or not Illuminas sequencing system could produce full DNA 
profiles at lower concentrations. This is especially important in forensic genetics, when sample 
obtained from crime scenes often can be low in amount and or very degraded. Figure 19 shows 
the allelic coverage of each sample. Between 1 ng and 250 pg DNA input, both control DNAs 
yielded a 100% DNA profile with no drop outs. And for the 2800M control DNA at 125 pg, a 
complete DNA profile was obtained. However, for two of the three 007 control DNA samples 
at 125 pg, one of the alleles had dropped out, giving an allele count of 98.8%. Samples with 
DNA amounts of 62.5 and 31.25 pg started to lose more alleles with both DNA controls. 
However, over 80% of the alleles were present in these samples. At 15.6 pg, only approximately 
half of the alleles where present in the DNA profile.  
D19S433 was the marker which most often had allelic dropouts (n=13), 4 and 9 times for 
respectively 2800M and 007 control DNA. And despite full profiles being achieved at 125 pg 
DNA, approximately 12 markers were flagged for artefacts such as stutters or imbalances. As 
the DNA concentration decreases, also the number of flags for imbalances and number of 
























Figure 19. Allelic counts for a dilution series of two DNA controls, 2800M and 007, analysed in triplets. Complete 








































 TECHNICAL RESULTS  
 
When obtaining complete DNA-profiles for all the samples in the Norwegian population sample 
from the biobank, many samples had to be re-sequenced because certain STR or SNP markers 
had incomplete or missing results. This also means that samples that already had complete STR-
profiles but were incomplete for even a single SNP were re-sequenced despite that this 
information was not necessary for this study focussing on the autosomal STR markers only.  In 
the end, sequencing results from a previous study (38, 46) and this study were combined for 
data analyses. If samples had low total coverage, this could often be traced back to errors done 
in the lab, such as evaporation of the samples during PCR or possibly manual errors such as 
pipetting. When dealing with so many samples and pipetting such small amounts errors can 
easily occur. In addition to this, one of the reagent lots of the ForenSeq DNA Signature Prep 
kit used gave incomplete results for certain SNP markers. It took some runs to understand the 
problem. In the end, the manufacturer replaced this low quality reagent lot, and the affected 
samples were re-sequenced with new reagents.  
One of the aims of this study was to finalize the sequencing project on the Norwegian 
population and to obtain complete DNA profiled for all 231 forensic genetic markers. This goal 
was almost completed. There are 20 samples left that need to be re-sequenced, because they 
have missing or inconclusive results in some SNP markers. Sequencing of the research biobank 
samples was stopped, because all the information on autosomal STRs needed to conclude this 
study was obtained, and time was running out to complete this thesis.  
The standard procedure was further modified by adding the Qubit measuring step. This was 
done to measure the DNA quantity of each sample after the library had been purified and before 
normalization. The purpose of adding this step was to estimate how the samples/lots were going 
to behave in sequencing. For example, if a sample has a high DNA quantity at this point and 
the sequencing result is poor the error has probably occurred during normalization or pooling 
the libraries, as long as the sequencing run itself is approved. By storing the measured DNA 
quantities, the performance of different lots can be compared. When receiving new kit lots, the 





similar compared to the previous reagent lot.  In this study, Qubit measurements have been very 
helpful and should therefore be considered as a permanent part of the standard procedure.  
 
 
4.1.1  PERFORMANCE OF THE FORENSEQ DNA SIGNATURE PREP KIT  
 
Based on previous experience by FGC (38, 46), the amount of pooled normalized library used 
for sequencing was raised from the recommended 7 µl to 14 µl. This was done to ensure 
sequencing results within the parameters set by the manufacturer, with highest possible cluster 
density yet avoiding overload, and also to ensure the maximum possible number of reads per 
sample and marker. Increased amount of pooled normalized library for sequencing has also 
been used in other studies, such as Devesse et al. 2018 (52) who used 12µl , as well as Novroski 
et al. 2016 (53) who used 10µl.  
The cluster density values obtained by all runs were within the parameters and are therefore 
considered as representative values for the other sequencing runs performed in this study. In 
studies conducted by Churchill et al. 2016 and Xavier et al. 2017, cluster densities of 716 
K/mm2 and 607 K/mm2 were obtained when using the recommended amount of pooled library 
(7µl) (85, 86). These cluster density values are within but at the low end of the optimal range 
set by the manufacturer. Although the cluster density obtained by these two studies are 
approved by the manufacturer, there can be drawn a correlation between amount of input library 
and cluster density. The cluster density in this study was between 1100-1500 K/mm2 using 14 
µl pooled library compared to 600-700 K/mm2 by Churchill et al. 2016 and Xavier et al. 2017, 
using 7 µl. When comparing these results, it seems as if by doubling the input amount the cluster 
density also doubles. Individual differences between instruments may also contribute to the 
difference in cluster density values when using the same amount of pooled normalized library. 
Further research could be performed to obtain the optimal input amount, since this is not already 
specified by the manufacturer.  
A total of 4 sequencing runs were chosen to evaluate the performance of two reagent lots of the 
ForenSeq DNA Signature Prep kit. In general, the obtained values for Qubit measurements, 
cluster density, and the number of reads/coverage per sample from the 4 runs were quite similar. 





anyway. This means that the Index CV, 43.7 % for one of the runs in lot 1 had a failed sample. 
All the other Index CV values are between 32.5 and 38.1 %. 
STR marker performance was evaluated, involving locus coverage, allele balance within 
markers, markers flagged with imbalance and stutters that were not filtered by the software. 
Locus coverage of the STR were quite variable. However, the STR marker with the lowest 
coverage for lot 1 and 2 was VWA and D19S433, respectively. The STR markers with the 
highest coverage for lot 1 and 2 was D20S482 and TH01, respectively. The three markers with 
the lowest allele balance were D1S1656, D5S818 and D22S1045. In addition, they had large 
standard deviations, which indicated that they were more variable between individuals than the 
other autosomal STRs.   
D19S433 has quite a high standard deviation for its allele balance, although the allele balance 
itself is similar to the rest of the markers. This could possibly be explained by the low coverage 
in lot 2, which could have led to a more variable result.  
The markers flagged frequently for imbalance correlate well with the markers with low allele 
balance. Lot 1 had a total of 72 flagged markers, whilst lot 2 had a total of 103. This indicates 
that lot 2 may have worse allele balances than lot 1, which means there could be variations 
between different lots and that it could be worth checking when receiving new lots for analysis. 
There are several people contributing with DNA to the stain, DNA-profile is more difficult to 
interpret if markers have poor allele balances.   
Some alleles designated as alleles by the UAS slipped through the stutter filter and were called 
as alleles by the software. These had to be manually removed from the DNA-profile. Overall, 
there was no obvious difference in the number of unfiltered stutters observed in each lot, but 
there may be differences in individual markers such as D6S1043, D19S433 and D17S1301. 
Interestingly, the markers with most unfiltered stutters in lot 1 seem to be less effected in lot 2 
and vice versa. However, the sample size may be too small to make a definitive conclusion. 
Even though the mistake alleles are relatively few, a person is still needed to go thoroughly 
through all the results after sequencing. It is however, hard to conclude anything because the 
sample size of this particular study is relatively small. Increased levels of stuttering and 
imbalances detected between lots may indicate that the PCR in the affected lot is working less 
optimally. Unfiltered stutters also make it harder to interpret mixed DNA samples with minor 





the true alleles. An idea could be to perform a more thorough stutter study, similar to Hussing 
et al. 2018 (87). A new study could lead to the adjustment of the stutter filter values in the UAS, 
making the results more reliable.  
 
 
 REPRODUCIBILITY OF THE MISEQ FGX FORENSIC GENOMIC SYSTEM 
 
Since so many samples were sequenced more than once there was sufficient data available to 
test the reproducibility of the MiSeq FGx Forensic Genomic System. Sample run results with 
low coverage were disregarded, as well as samples that had inconclusive results for any of the 
autosomal STR-markers, meaning having one allele call below the interpretation threshold set 
in the Universal Analysis software. Additionally, all profiles were manually inspected and 
evaluated for potential stutters and other artefacts. The final approved STR-profiles showed that 
results obtained with the ForenSeq DNA Genomic System are 100% reproducible. Jäger et al. 
2017 (93) also evaluated reproducibility in their study. Using DPMB they analysed 231 loci 5 
times using five different researchers. Although, they did not include STR locus D22S1045 in 
their study, because the primer set was still in development during this time, they yielded a 
100% reproducible result for the other markers.  
Reproducibility is an important aspect of the validation process that is carried out whenever 
new reagents and instruments are tested before implementing them in forensic casework (62, 
63). Reproducibility of methods is so crucial because the obtained results are more trustworthy, 
bring a level of transparency to the method and raise the credibility and understanding of what 
was done with a sample when for example presenting the results in court.  
 
 CONCORDANCE BETWEEN THE SIGNATURE PREP KIT AND THE NGM SELECT 
KIT (THERMOFISHER SCIENTIFIC) 
 
Only the overlapping markers between two methods can be used to perform a concordance 





profiling. The goal was to see if concordant results for length-based allele calls could be 
produced with the Signature Prep kit. A concordance of 99.99% (32397 out of 32400 alleles) 
was achieved. There were only two STR markers that showed discordance between the two 
kits, D22S1045 and D1S1656.  
In a study conducted by Hussing et al. 2018, 30 samples were typed with the AmpFLSTR NGM 
SElect Express PCR Amplification Kit and the ForenSeq kit. Out of their 450 STR genotypes 
tested, 448 (99.6%) were found to be concordant. The two discordances were drop-ins in 
D21S11 in the PCR-CE assay (88). In another study, by Garcia et al. 2011, concordance was 
done between three kits. The Identifiler-NGM, PowerPlex ESX17 and the Investigator ESS 
systems. They yielded a 99.99% concordance. The only discordances were due to null alleles 
in the vWA marker (89). Gettings et al. 2016 (90) also evaluated the concordance between 
length-based CE and NGS genotypes for 183 samples (4392 loci in total). They also observed 
~99% concordance between the two methods.  
It seems common that rare discordances occur when using different reagent kits. Discordances 
may be caused by using different primers in the kits compared. If a primer binding site for one 
of the markers mutates in one of the kits, this may lead to less amplification product or no 
product at all, i.e. a null allele, in the other kit, as was found in the study by Garcia et al. 2011. 
 
 SENSITIVITY STUDY  
 
In forensic genetics and in DNA analysis the ability to yield usable DNA profiles/results from 
degraded or damaged samples is critical. Evidence samples from biological stains are often in 
poor condition for several reasons, for example caused by environmental conditions. Damaged 
and degraded DNA does not perform well in PCR amplification because it hinders 
polymerization (91, 92). This in turn can lead to partial or no DNA profiles at all. In addition, 
PCR artefacts can potentially yield incorrect genotypes in the DNA profile. A solution to this 
problem has been developed and utilized in for example the MiSeq FGx Forensic Genomics 
System from Illumina. They say having employed steps to raise the analysis sensitivity. PCR 
cycle number has been increased, amplicon sizes have been reduced, and the amplicons are 






Therefore, the purpose of this sensitivity study was to explore how little DNA could be used in 
the ForenSeq DNA Signature Prep kit and still yield complete DNA profiles. The results show, 
that complete DNA-profiles (no allelic dropouts) are still detected with 125 pg DNA input. The 
only exception is for two of the 007 control DNA triplets, where one allele fell out, making 
their profile 98.8% complete. 62.5 pg and 31.25 pg samples had over 80% full DNA-profiles, 
for both control DNAs. Even with 15,625 pg DNA (007 control DNA), approximately 50% of 
the alleles were called. Jäger et al. 2017 (98) also performed a sensitivity study using DPMB 
and quadruple samples ranging from 1 ng down to 7.82 pg DNA. Their results did however 
show even higher sensitivity than performed in this study. DNA inputs ranging from 1ng down 
to 62.5 pg yielded complete profiles. Whilst 15.625 pg and 7.82 pg DNA yielded a 70% and 
50% allele call, respectively. 
Despite complete DNA-profiles being achieved with 125 pg DNA in this study, approximately 
12 markers were flagged for artefacts such as stutters or imbalances. As DNA concentrations 
decrease, the number of stutters that are called as alleles and imbalances increases (data not 
shown). However, after manual assessment, the genotypes are found to be correct. This could 
however, have an impact on mixed DNA samples. The increase in allele calls will make it 
harder to accurately interpret the results.  
Fattorini et al. 2017 (99) performed a sensitivity study with the commercial kit PowerPlex® 
ESI 17 system and the 3500 Genetic Analyser Sequencer (Thermo Fisher Scientific) for CE 
analysis. When using the DNA amount of 55 pg DNA, no results were produced. 
At a first glance, the results in this study show that the sensitivity of the ForenSeq DNA 
Signature Prep kit may be equivalent to CE-based kits, i.e. producing complete DNA-profiles 
with 125 pg (100). However, the Signature Prep kit has an advantage, especially in forensic 
genetics cases where the samples used may be of low quantity and quality. As little as 15 pg 
DNA can still yield 50% allele calls. With CE, the DNA-profiles of so little DNA would only 
contain a few or none alleles. Thus, the ForenSeq DNA Signature Prep is more sensitive than 
CE-methods. Some trace evidence sample that effectively would not yield any results using CE 








 POPULATION DATABASE 
 
There were only three markers, which did not fulfil the HWE: D21S11, vWA and Penta D.  
They all had p values less than 0.05. Most of the loci were not in LD, but there were a couple 
of loci that were not entirely unlinked, such as FGA, Penta D and TPOX.  
The importance of having unlinked loci is so that when allele and genotype frequencies are 
being estimated correctly. When for dealing with example linked loci or the markers differ from 
HWE it may indicate genotyping errors, the populations structure might not be as expected, 
homologous regions in the genome, then is to prevent errors in genotyping.  
The PCA is used to determine the population’s substructure and quality control. The PCA in 
the figure shows a slightly scattered cluster with two obvious outliers only. This is indicating 
that there is little population substructure in the Norwegian population sample despite having 
included…. The outlier samples were checked back in the database and their heritage confirmed 
as African.  
The STRAF analysis, including the PCA plot, were not separated into more populations, even 
though the population used was including individuals with more than strictly Norwegian 
heritage. The number of individuals from other origin is not sufficient to separate the dataset 
into several subpopulations. Due to the compound population that lives here in Northern 
Norway, specifically the university, students and employees from all over the world come to 
study and work in Tromsø. Therefore, the individuals in the research databank are from 
different places in the world, explaining the slight scattering in the PCA plot.  
The first length-based allele frequencies were calculated. These can be used for further 
calculations/research and to calculate the statistical weight of DNA evidence to present to the 
court. The most polymorphic marker based on length-based alleles is FGA with 19 alleles, 
whilst the least polymorphic marker is D4S2408 with only 5 alleles in the Norwegian 
population sample. Devesse et al. 2018 (52) characterized two populations, the White British 
and the British Chinese. Their most polymorphic length-based marker differs? between the two 
populations, D12S391 and FGA for the White British and the British Chinese population, 
respectively. Their least polymorphic markers were TPOX and D4S2408 for the White British 







 SEQUENCE VARIATION  
 
Characterization of sequence-based alleles and allele frequencies was obtained, but 
unfortunately novel alleles remain to be characterized. this needs to be done and comparison to 
other populations as well. Optimally the new alleles variants should be compared to other 
studies conducted, but only Devesse et al. was obtained. For future projects this part of the 
study should be finalized. And properly characterized for novel alleles.  
By characterizing the sequence-based alleles and comparing them to the length-based alleles, 
an increase in number of alleles is found in many markers. Eight of the twenty-seven markers 
did not show an increase of allele numbers between the two methods. Compared to Devesse et 
al. 2018 (52), the results in this study differ slightly. They found that the alleles increased in 
number by sequence variation for all markers except Penta D, Penta E, D22S1045, D16S539, 
TPOX, TH01, D10S1248, and D19S433. However, Novroski et al. 2016 (53) found sequence 
variation in all markers except for TPOX. This might be due to their sample size (n=777) and 
the fact that they analysed four different populations groups (52).  
In this study the most polymorphic marker based on a sequence based allele separation method 
is D12S391, which is concordant with results by Devesse et al. 2018 (52). This Autosomal STR 
marker showed an increase of 49 alleles. Because sequencing increased the number of alleles 
for many of the markers compared to CE, and for some considerably, sequencing helps to raise 
the power of discrimination when comparing the DNA-profiles of reference persons with the 
DNA-profile of a biological stain collected at a crime scene. This means that individuals with 
identical length-based alleles can have different sequence-based alleles, which makes it possible 
to more easily separate them in DNA mixtures.    
Each population can contain different sequences, as shown in this study where novel sequences 
were discovered. By several studies analysing different populations, we build our understanding 
of different allelic compositions around the world. And it enables us to compare the populations 








5 CONCLUSION AND FUTURE PERSPECTIVES  
 
The aim of obtaining full DNA profiles for all 231 forensic genetic markers included in the 
ForenSeq DNA Signature Prep kit for all samples in the Norwegian population from the 
research biobank was almost finalized in this study. A full autosomal STR-profile was obtained 
for all samples. There are approximately 20 samples left that need to be re-sequenced to 
complete the full 231 genetic markers for all the DNA profiles.  
The validation data for the MiSeq FGx Forensic Genomic System was achieved. The data 
shows that the system has relatively good performance between two representative lots, with 
small differences, especially with STR marker performance which may indicate lot to lot 
variation.  
The analyses also show that the ForenSeq DNA Signature Prep kit can produce reproducible 
genotyping results for autosomal STR-markers. The concordance in genotypes between this kit 
and the NGM Select kit was 99.99%, which is in line with others when comparing different 
reagent kits. 
The sensitivity study showed that a complete DNA-profile could be obtained with 125 pg DNA. 
Because partial profiles with 50% of alleles were still obtainable with 15.625 pg DNA, the 
ForenSeq DNA Signature Prep kit is more sensitive than more established CE-based methods.  
 
The Norwegian population database of autosomal STR allele frequencies for Norway based on 
fragment length was obtained during this study, which can now be used to calculate the 
statistical weight of evidence in cases concerning the Norwegian population.  
Allele frequencies of the SB alleles are obtained but novel variants need to be further examined. 
Due to lack of time the only study these sequences could be compared to was Devesse et al. but 
they in turn compared their data to many other studies. Unfortunately, time ran out on this part 
of the thesis, and the aim of Defining autosomal STR-alleles based on sequence variation using 
the MiSeq FGx Forensic Genomic System was not completed. 
 
By completing the Norwegian population database and obtaining the length based allele 





calculations. If we recall, Mr. Petersen was accused of killing a young girl. The question was: 
what is the probability that the obtained DNA was deposited by Mr. Petersen. And what is the 
probability that another member of the population could have contributed to the mixed DNA 
sample obtained from under the victims’ fingernails. By using the newly obtained allele 
frequencies, statistical calculations can now be used to calculate the weight of the evidence to 
help determine the answers to these questions.  
In the future, studies involving the analysis of other biological trace samples, as for example 
fingerprints or skin cells and also DNA mixtures from several contributors should be conducted 
to test and validate the performance of the kit further. 
Another study that could be conducted in the future would be a study analysing the sequence 
variation within the flanking regions of the markers. Within the markers there can be novel 
variant which also may help raise the power of discrimination when it comes to trace samples 
in a case.  
In this study, the autosomal STRs were the focus, future projects could look at the other markers 
in the kit and design studies around them, similar to the study performed by Hussing et al. 2015 
(56) which focused on the eye colours of the individuals they analysed.  
And lastly, to further build on this study a future project might perform a similar study to Vilsen 
et al. 2018 (87), which was a stutter analysis of STRs using the MiSeq FGx Forensic Genomics 
System. To learn more about the stutters that form during sequencing and the rate at which they 
do so, and maybe learn different ways in how to identify stutters and call them correctly. This 














6 REFERENCES  
 
1. Butler JM. Fundamentals of Forensic DNA Typing. National Institute of Standards and Technology. 
Gaithersburg, Maryland, USA: Elsevier; 2010. 500 p. 
2. Olaisen B. Rettsgenetikk: Store medisinske leksikon; 2009 [cited 2018 31.03]. Available from: 
https://sml.snl.no/rettsgenetikk  
3. Sir Alec Jeffreys The Forensics Library: The Forensics Library;  [cited 2018 01.04]. Available from: 
http://aboutforensics.co.uk/sir-alec-jeffreys/. 
4. The Discovery of DNA Fingerprinting: DNA Forensics;  [cited 2018 01.04]. Available from: 
http://www.dnaforensics.com/DNAFingerprinting.aspx. 
5. Saad R. Discovery, development, and current applications of DNA identity testing. Proceedings (Baylor 
University Medical Center). 2005;18(2):130-3. 
6. Falch-Nilsen K. Metoden som løser alt. 2013. 
7. Ommundsen EG. Felles av genetiske avtrykk. dagsavisen. 2013. 
8. Valones MAA, Guimarães RL, Brandão LAC, de Souza PRE, de Albuquerque Tavares Carvalho A, Crovela 
S. Principles and applications of polymerase chain reaction in medical diagnostic fields: a review. Brazilian 
Journal of Microbiology. 2009;40(1):1-11. 
9. Ginther C, Issel-Tarver L, King MC. Identifying individuals by sequencing mitochondrial DNA from teeth. 
Nature genetics. 1992;2(2):135-8. 
10. Sullivan KM, Hopgood R, Gill P. Identification of human remains by amplification and automated 
sequencing of mitochondrial DNA. International journal of legal medicine. 1992;105(2):83-6. 
11. Genetic fingerprinting explained University of Leicester;  [cited 2018 01.04]. Available from: 
https://www2.le.ac.uk/departments/genetics/jeffreys/explained. 
12. Panneerchelvam S, Norazmi MN. Forensic DNA Profiling and Database. The Malaysian Journal of 
Medical Sciences : MJMS. 2003;10(2):20-6. 
13. Børresen-Dale A-L. Dna Typing I Store medisinske leksikon2014 [cited 2018 26.02]. Available from: 
https://sml.snl.no/DNA-typing. 
14. David Carmody JS, Siri Atma W. Greeley,  Graeme I. Bell, Louis H. Philipson. Genetic Diagnosis of 
Endocrine Disorders (Second edition). 2 ed: Academic Press; 2016. 
15. Forensic DNA Testing Systems, Short Tandem Repeats (STRs)  [cited 2018 26.02]. Available from: 
http://www.forensicdnacenter.com/index.html  
16. Advances in Forensics Provide Creative Tools for Solving Crimes Bulletin of the Connecticut Academy 
of Science and Engineering2004 [cited 2018 27.02]. 19,2:[Available from: 
http://www.ctcase.org/bulletin/19_2/forensics.html. 
17. Autosomal DNA Profiling SecuriGene Technologies Inc [cited 2018 26.02]. Available from: 
https://www.securigene.com/dna-testing/autosomal-dna-profiling/. 
18. Methods in DNA Analysis. Short Tandem Repeats (STR) / Microsatellites Kitalah Gigi: Kitalah Gigi;  
[Available from: http://kitalahgigi.blogspot.no/2014/11/methods-in-dna-analysis.html. 
19. DNA-analyser, farskapstest og andre slektskapstester – faktaark Oslo Universitetssykehus2017 [cited 
2018 25.04]. Available from: https://oslo-universitetssykehus.no/fag-og-forskning/nasjonale-og-regionale-
tjenester/rettsmedisinske-fag/dna-analyser/dna-analyser-farskapstest-og-andre-slektskapstester-faktaark. 
20. Bishop A, Schiestl R. Homologous Recombination and Its Role in Carcinogenesis2002. 75-85 p. 
21. Viguera E, Canceill D, Ehrlich S. Replication slippage involves DNA polymerase pausing and dissociation. 
The EMBO Journal. 2001;20(10):2587-95. 
22. Butler JM. Advanced Topics in Forensic DNA Typing: Methodology. 1 ed. National Institute of 





23. Schneider PM. Expansion of the European Standard Set of DNA Database Loci—the Current 
Situation2009. 
24. Martin PD, Schmitter H, Schneider PM. A brief history of the formation of DNA databases in forensic 
science within Europe. Forensic Science International. 2001;119(2):225-31. 
25. Gill P, Fereday L, Morling N, Schneider PM. The evolution of DNA databases—Recommendations for 
new European STR loci. Forensic Science International. 2006;156(2):242-4. 
26. Welch LAG, P. Phillips, C. Ansell, R. Morling, N. Parson, W. Palo, J. U. Bastisch, I. European Network of 
Forensic Science Institutes (ENFSI): Evaluation of new commercial STR multiplexes that include the European 
Standard Set (ESS) of markers. Forensic Science International: Genetics. 2012;6(6):819-26. 
27. Canturk KM, Gurkan C, Sevay H, Emre R. Evaluation of the genetic parameters for 10 common and five 
new ESS core autosomal STR loci in seven major geographic regions and the largest metropolitan province of 
Turkey. Annals of Human Biology. 2017;44(2):149-63. 
28. Chakraborty R. Sample size requirements for addressing the population genetic issues of forensic use 
of DNA typing. Human biology. 1992;64(2):141-59. 
29. Steele CD, Balding DJ. Choice of population database for forensic DNA profile analysis. Science & 
justice : journal of the Forensic Science Society. 2014;54(6):487-93. 
30. Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proceedings of the 
National Academy of Sciences of the United States of America. 1977;74(12):5463-7. 
31. Maxam AM, Gilbert W. A new method for sequencing DNA. Proceedings of the National Academy of 
Sciences of the United States of America. 1977;74(2):560-4. 
32. Tucker T, Marra M, Friedman JM. Massively Parallel Sequencing: The Next Big Thing in Genetic 
Medicine. American Journal of Human Genetics. 2009;85(2):142-54. 
33. Introduction to NGS- Learn how the technology works and what it can do for you Illumina2018 [cited 
2018 28.04]. Available from: https://emea.illumina.com/science/technology/next-generation-
sequencing.html?langsel=/af/. 
34. Behjati S, Tarpey PS. What is next generation sequencing? Archives of Disease in Childhood Education 
and Practice Edition. 2013;98(6):236-8. 
35. Margulies M, Egholm M, Altman WE, Attiya S, Bader JS, Bemben LA, et al. Genome sequencing in 
microfabricated high-density picolitre reactors. Nature. 2005;437(7057):376-80. 
36. An introduction to Next-Generation Sequencing Technology Illumina2017 [cited 2018 28.04]. Available 
from: https://www.illumina.com/content/dam/illumina-
marketing/documents/products/illumina_sequencing_introduction.pdf. 
37. Eduardoff M, Santos C, de la Puente M, Gross TE, Fondevila M, Strobl C, et al. Inter-laboratory 
evaluation of SNP-based forensic identification by massively parallel sequencing using the Ion PGM. Forensic 
science international Genetics. 2015;17:110-21. 
38. Zakariassen M. Predicting visible traits in a Norwegian population A prototype SNP panel for massive 
parallel sequencing [Msc]: Arctic University of Tromsø; 2016. 
39. Yang Y, Xie B, Yan J. Application of Next-generation Sequencing Technology in Forensic Science. 
Genomics, Proteomics & Bioinformatics. 2014;12(5):190-7. 
40. Metzker ML. Sequencing technologies - the next generation. Nature reviews Genetics. 2010;11(1):31-
46. 
41. Borsting C, Morling N. Next generation sequencing and its applications in forensic genetics. Forensic 
Science International: Genetics. 2015;18:78-89. 
42. Shendure J, Ji H. Next-generation DNA sequencing. Nature Biotechnology. 2008;26:1135. 








44. Technology Overview Centre for Genomic Sciences [cited 2018 01.03]. Available from: 
http://cgs.hku.hk/portal/index.php/pyrosequencing/technology-overview. 
45. Sequencing-by-Synthesis: Explaining the Illumina Sequencing Technology BitesizeBio [cited 2018 
01.03]. Available from: https://bitesizebio.com/13546/sequencing-by-synthesis-explaining-the-illumina-
sequencing-technology/. 
46. Kirsebom MK. Forensic DNA phenotyping  SNP-based prediction of eye and hair colour in the 
Norwegian population Arctic University of Tromsø; 2016. 
47. Targeted Next-Generation Sequencing for Forensic Genomics. illumina Illumina2015 [cited 2018 
27.02]. Available from: https://emea.illumina.com/content/dam/illumina-
marketing/documents/products/appspotlights/app_spotlight_forensics.pdf  




49. Ratan A, Miller W, Guillory J, Stinson J, Seshagiri S, Schuster SC. Comparison of Sequencing Platforms 
for Single Nucleotide Variant Calls in a Human Sample. PLoS ONE. 2013;8(2):e55089. 
50. Rieber N, Zapatka M, Lasitschka B, Jones D, Northcott P, Hutter B, et al. Coverage bias and sensitivity 
of variant calling for four whole-genome sequencing technologies. PLoS One. 2013;8(6):e66621. 
51. Ozsolak F. Third Generation Sequencing Techniques and Applications to Drug Discovery. Expert 
Opinion on Drug Discovery. 2012;7(3):231-43. 
52. Laurence Devesse DB, Lucinda Davenport Immy Riethorst, Gabriella Mason-Buck, Denise Syndercombe 
Court. Concordance of the ForenSeq™ system and characterisation of sequence-specific autosomal STR alleles 
across two major population groups. Forensic Science International: Genetics. 2018;34:57-61. 
53. Novroski NMM, King JL, Churchill JD, Seah LH, Budowle B. Characterization of genetic sequence 
variation of 58 STR loci in four major population groups. Forensic science international Genetics. 2016;25:214-
26. 
54. Butler JM. The future of forensic DNA analysis. Philosophical transactions of the Royal Society of 
London Series B, Biological sciences. 2015;370(1674). 
55. Butler JM, Coble MD, Vallone PM. STRs vs. SNPs: thoughts on the future of forensic DNA testing. 
Forensic science, medicine, and pathology. 2007;3(3):200-5. 
56. Hussing C, Børsting C, Mogensen HS, Morling N. Testing of the Illumina ForenSeq kit. Forensic Science 
International: Genetics Supplement Series.5:e449-e50. 
57. Pitterl F, Schmidt K, Huber G, Zimmermann B, Delport R, Amory S, et al. Increasing the discrimination 
power of forensic STR testing by employing high-performance mass spectrometry, as illustrated in indigenous 
South African and Central Asian populations. International journal of legal medicine. 2010;124(6):551-8. 
58. Kline MC, Hill CR, Decker AE, Butler JM. STR sequence analysis for characterizing normal, variant, and 
null alleles. Forensic science international Genetics. 2011;5(4):329-32. 
59. Sun JX, Helgason A, Masson G, Ebenesersdottir SS, Li H, Mallick S, et al. A direct characterization of 
human mutation based on microsatellites. Nature genetics. 2012;44(10):1161-5. 
60. Gettings K, Kiesler K, A. Faith S, Montano E, Baker C, Young B, et al. Sequence variation of 22 
autosomal STR loci detected by next generation sequencing2015. 
61. Gettings KB, Aponte RA, Vallone PM, Butler JM. STR allele sequence variation: Current knowledge and 
future issues. Forensic science international Genetics. 2015;18:118-30. 
62. Validation Guidelines for DNA Analysis Methods: Scientific Working Group on DNA Analysis Methods 
(SWGDAM); 2016 [updated 12.05.2016; cited 2018 25.04]. Available from: 
https://docs.wixstatic.com/ugd/4344b0_813b241e8944497e99b9c45b163b76bd.pdf. 
63. Recommended Minimum Criteria for the Validation of Various- Aspects of the DNA Profiling Process 






64. De Souza YG, Greenspan JS. Biobanking Past, Present and Future: Responsibilities and Benefits. AIDS 
(London, England). 2013;27(3):303-12. 
65. What is a biobank? Genetic Alliance, Registry and BioBank [Available from: 
http://www.biobank.org/toolbox/start_a_biobank/basics_and_benefits. 
66. QIAamp® DNA Investigator Handbook Protocol: Isolation of Total DNA from Small Volumes of Blood or 
Saliva: QIAGEN; 2012 [cited 2018 29.03]. Available from: 
https://www.qiagen.com/kr/resources/resourcedetail?id=dcc5a995-3743-4219-914d-94d6a28e49b3&lang=en. 
67. Quantifiler™ HP and Trio DNA Quantification Kits USER GUIDE revision G Thermo Fisher Scientific 2017 
[cited 2018 27.03]. Available from: https://tools.thermofisher.com/content/sfs/manuals/4485354.pdf. 
68. INNOQUANT® HY. COMPATIBLE WITH COMMONLY USED REAL-TIME PCR INSTRUMENTS & SOFTWARE 
InnoGenomics [cited 2018 24.04]. Available from: http://innogenomics.com/products/innoquant-hy/. 




70. Applied Biosystems Veriti™ Thermal Cycler User Guide Rev. E: Thermofisher; 2010 [cited 2018 30.03]. 
Available from: https://tools.thermofisher.com/content/sfs/manuals/cms_042832.pdf. 
71. Qubit® dsDNA HS Assay Kits B.0 Thermo Fisher Scientific Inc; 2015 [cited 2018 23.03]. Available from: 
https://tools.thermofisher.com/content/sfs/manuals/Qubit_dsDNA_HS_Assay_UG.pdf. 
72. Focused forensic power Illumina [cited 2018 24.04]. Available from: 
https://emea.illumina.com/systems/sequencing-platforms/miseq-fgx.html?langsel=/af/. 




74. Sequencing Technology Video  [cited 2018 02.03]. Available from: 
https://emea.illumina.com/science/technology/next-generation-sequencing/illumina-sequencing-history.html  
75. NGS technology CeGaT [Available from: https://www.cegat.de/en/services/next-generation-
sequencing/. 
76. Illumina Sequencing Technology Illumina: Illumina;  [cited 2018 21.03]. Available from: 
https://www.illumina.com/documents/products/techspotlights/techspotlight_sequencing.pdf. 
77. Sharma G. What is the mechanism that cleave reverse strand on flow cell and leaving forward strand 
as template of sequencing in Illumina's platform? ResearchGate2015 [cited 2018 24.04]. Available from: 
https://www.researchgate.net/post/What_is_the_mechanism_that_cleave_reverse_strand_on_flow_cell_and
_leaving_forward_strand_as_template_of_sequencing_in_Illuminas_platform. 




79. Walsh PS, Fildes NJ, Reynolds R. Sequence analysis and characterization of stutter products at the 
tetranucleotide repeat locus vWA. Nucleic Acids Research. 1996;24(14):2807-12. 
80. Gouy A, Zieger M. STRAF—A convenient online tool for STR data evaluation in forensic genetics. 
Forensic Science International: Genetics. 2017;30:148-51. 
81. Novembre J, Stephens M. Interpreting principal component analyses of spatial population genetic 
variation. Nature genetics. 2008;40(5):646-9. 
82. Barker DF. What is the difference between Linkage Equilibrium and Linkage Disequilibrium? Research 







83. Just RS, Moreno LI, Smerick JB, Irwin JA. Performance and concordance of the ForenSeq™ system for 
autosomal and Y chromosome short tandem repeat sequencing of reference-type specimens. Forensic Science 
International: Genetics. 2017;28:1-9. 
84. Parson W, Ballard D, Budowle B, Butler JM, Gettings KB, Gill P, et al. Massively parallel sequencing of 
forensic STRs: Considerations of the DNA commission of the International Society for Forensic Genetics (ISFG) 
on minimal nomenclature requirements. Forensic Science International: Genetics. 2016;22:54-63. 
85. Xavier C, Parson W. Evaluation of the Illumina ForenSeq™ DNA Signature Prep Kit – MPS forensic 
application for the MiSeq FGx™ benchtop sequencer. Forensic Science International: Genetics. 2017;28:188-94. 
86. Churchill JD, Schmedes SE, King JL, Budowle B. Evaluation of the Illumina® Beta Version ForenSeq™ 
DNA Signature Prep Kit for use in genetic profiling. Forensic Science International: Genetics. 2016;20:20-9. 
87. Vilsen SB, Tvedebrink T, Eriksen PS, Bøsting C, Hussing C, Mogensen HS, et al. Stutter analysis of 
complex STR MPS data. Forensic Science International: Genetics. 2018;35:107-12. 
88. Hussing C, Huber C, Bytyci R, Mogensen HS, Morling N, Børsting C. Sequencing of 231 forensic genetic 
markers using the MiSeq FGx™ forensic genomics system – an evaluation of the assay and software. Forensic 
Sciences Research. 2018:1-13. 
89. García O, Alonso J, Cano JA, García R, Luque GM, Martín P, et al. Population genetic data and 
concordance study for the kits Identifiler, NGM, PowerPlex ESX 17 System and Investigator ESSplex in Spain. 
Forensic Science International: Genetics. 2012;6(2):e78-e9. 
90. Gettings KB, Kiesler KM, Faith SA, Montano E, Baker CH, Young BA, et al. Sequence variation of 22 
autosomal STR loci detected by next generation sequencing. Forensic Science International: Genetics. 
2016;21:15-21. 
91. Eckert KA, Kunkel TA. DNA polymerase fidelity and the polymerase chain reaction. PCR methods and 
applications. 1991;1(1):17-24. 
92. Alaeddini R, Walsh SJ, Abbas A. Forensic implications of genetic analyses from degraded DNA--a 
review. Forensic science international Genetics. 2010;4(3):148-57. 
93. Diegoli TM, Farr M, Cromartie C, Coble MD, Bille TW. An optimized protocol for forensic application of 
the PreCR Repair Mix to multiplex STR amplification of UV-damaged DNA. Forensic science international 
Genetics. 2012;6(4):498-503. 
94. Smith PJ, Ballantyne J. Simplified low-copy-number DNA analysis by post-PCR purification. Journal of 
forensic sciences. 2007;52(4):820-9. 
95. Coble MD, Butler JM. Characterization of new miniSTR loci to aid analysis of degraded DNA. Journal of 
forensic sciences. 2005;50(1):43-53. 
96. Butler JM, Shen Y, McCord BR. The development of reduced size STR amplicons as tools for analysis of 
degraded DNA. Journal of forensic sciences. 2003;48(5):1054-64. 
97. Forster L, Thomson J, Kutranov S. Direct comparison of post-28-cycle PCR purification and modified 
capillary electrophoresis methods with the 34-cycle "low copy number" (LCN) method for analysis of trace 
forensic DNA samples. Forensic science international Genetics. 2008;2(4):318-28. 
98. Jäger AC, Alvarez ML, Davis CP, Guzmán E, Han Y, Way L, et al. Developmental validation of the MiSeq 
FGx Forensic Genomics System for Targeted Next Generation Sequencing in Forensic DNA Casework and 
Database Laboratories. Forensic Science International: Genetics. 2017;28:52-70. 
99. Fattorini P, Previdere C, Carboni I, Marrubini G, Sorcaburu-Cigliero S, Grignani P, et al. Performance of 
the ForenSeq(TM) DNA Signature Prep kit on highly degraded samples. Electrophoresis. 2017;38(8):1163-74. 
100. Ewing MM, Thompson JM, McLaren RS, Purpero VM, Thomas KJ, Dobrowski PA, et al. Human DNA 
quantification and sample quality assessment: Developmental validation of the PowerQuant¨r) system. 







7 APPENDIX  
 
Appendix I – Sequencing criteria for completed DNA profiles. 
 
Kriterier for konferering av NGS-resultater 
DNA-profilene skal være rene/fra en person 
 
STRer: 
Ekstra alleler i stutter posisjon fjernes hvis de er ca. på 10-15% av nabotoppen. 
Hvis det er et allel som er under den stokastiske terskelen i markører der det kan forekommer 
to alleler, tas ikke allelet med, og det legges en kommentar i prøveoversikten.  
For markører med manglende resultat legges en kommentar i prøveoversikten. 
 
SNPer: 
For markører med manglende resultat: en kommentar legges i prøveoversikten. 
Hvis markøren har et allel ≤ 30 reads fjernes resultatet for denne markøren (pga. mulig dropout). 
En kommentar legges i prøveoversikten. 
Hvis markøren har to alleler ≤ 30 reads eller et allel > 30 reads og et allel < 30 reads og 
allelbalansen er noenlunde, tas begge allelene med. 
Hvis et av allelene er < 10 %, tas dette allelet ikke med, og det legges en kommentar i 
prøveoversikten.  
Hvis et av allelene er mellom 10-20 % legges en kommentar i prøveoversikten. 
 






Markørtype (aSTR, Y-STR, X-STR, iSNP, pSNP, aSNP) 
Markørnavn  
Eventuelle kommentarer (uten kommentar = mangler resultat for denne markøren) 
Hvis det foreligger flere resultater for en prøve, sammenlignes disse for å se om alle markører 























APPENDIX IV - Characterization of sequence based autosomal STR alleles including allele 
frequencies.  
If a novel allele is characterized, it is marked red in the table, novel alleles are only checked up 
against Devesse et al. 2018 (52). Unfortunately, because of time restraint, not all markers where 
checked to see if there were any novel alleles. These markers include, FGA, D12, D19 and 
vWa.  











8 [AGAT]8 0,00093 
9 [AGAT]9 0,02037 
10 [AGAT]10 0,24630 
11 [AGAT]3[ATAT][AGAT]7 0,00093 
11 [AGAT]11 0,28704 
12 [AGAT]12 0,32593 
13 [AGAT]13 0,09537 
14 [AGAT]14 0,01296 












11 [GGAA]11 0,00463 
12 [GGAA]12 0,03889 
13 [GGAA]13 0,32130 
14 [GGAA]14 0,29444 
15 [GGAA]15 0,16944 
16 [GGAA]16 0,12593 
17 [GGAA]17 0,04444 










15 [AGAT]8[AGAC]6AGAT 0,05185 
16 [AGAT]9[AGAC]6AGAT 0,01574 
17 [AGAT]9[AGAC]7AGAT 0,00741 
17 [AGAT]10[AGAC]7 0,00093 
17 [AGAT]10[AGAC]6AGAT 0,11944 
17 [AGAT]11[AGAC]5AGAT 0,00463 
17,3 [AGAT]GAT[AGAT]8[AGAC]7AGAT 0,01852 
18 [AGAT]10[AGAC]7 0,00278 
18 [AGAT]11[AGAC]6AGAT 0,15926 
18 [AGAT]12[AGAC]5AGAT 0,01296 
18,3 [AGAT]GAT[AGAT]9[AGAC]7AGAT 0,00741 
19 [AGAT]11[AGAC]9 0,00093 
19 [AGAT]11[AGAC]7AGAT 0,02593 
19 [AGAT]12[AGAC]6AGAT 0,08889 





19,3 [AGAT]5GAT[AGAT]7[AGAC]6AGAT 0,00278 
19,3 [AGAT]GAT[AGAT]10[AGAC]7AGAT 0,00556 
20 [AGAT]11[AGAC]9 0,02963 
20 [AGAT]11[AGAC]8AGAT 0,00185 
20 [AGAT]12[AGAC]8 0,00741 
20 [AGAT]12[AGAC]7AGAT 0,0287 
20 [AGAT]13[AGAC]7 0,00278 
20 [AGAT]13[AGAC]6AGAT 0,03426 
20 AGGT[AGAT]10[AGAC]9 0,0037 
21 [AGAT]11[AGAC]10 0,0037 
21 [AGAT]12[AGAC]9 0,05926 
21 [AGAT]12[AGAC]8AGAT 0,00648 
21 [AGAT]13[AGAC]8 0,01019 
21 [AGAT]13[AGAC]7AGAT 0,01481 
21 [AGAT]14[AGAC]7 0,00093 
21 [AGAT]14[AGAC]6AGAT 0,00926 
22 [AGAT]11[AGAC]10AGAT 0,00093 
22 [AGAT]12[AGAC]10 0,02037 
22 [AGAT]12[AGAC]9AGAT 0,00278 
22 [AGAT]13[AGAC]9 0,05278 
22 [AGAT]13[AGAC]8AGAT 0,00741 
22 [AGAT]14[AGAC]8 0,01019 
22 [AGAT]14[AGAC]7AGAT 0,00185 
22 [AGAT]15[AGAC]6AGAT 0,00093 
23 [AGAT]12[AGAC]11 0,00463 
23 [AGAT]12[AGAC]10AGAT 0,00278 
23 [AGAT]13[AGAC]10 0,00833 
23 [AGAT]13[AGAC]9AGAT 0,01019 
23 [AGAT]14[AGAC]9 0,03796 
23 [AGAT]14[AGAC]8AGAT 0,01944 
23 [AGAT]15[AGAC]8 0,00278 
23 [AGAT]16[AGAC]6AGAT 0,00093 
24 [AGAT]12[AGAC]12 0,00093 
24 [AGAT]13[AGAC]11 0,0037 
24 [AGAT]13[AGAC]10AGAT 0,00093 
24 [AGAT]14[AGAC]10 0,00926 
24 [AGAT]14[AGAC]9AGAT 0,00278 
24 [AGAT]15[AGAC]9 0,01481 
24 [AGAT]15[AGAC]8AGAT 0,00926 
24 [AGAT]16[AGAC]8 0,00093 
24 [AGGT]15[AGAC]8AGAT 0,00185 
25 [AGAT]14[AGAC]11 0,00463 
25 [AGAT]14[AGAC]10AGAT 0,00093 
25 [AGAT]15[AGAC]10 0,00278 
25 [AGAT]16[AGAC]9 0,0037 





25 [AGGT][AGAT]15[AGAC]8AGAT 0,00093 
26 [AGAT]17[AGAC]9 0,0037 
26 [AGAT]17[AGAC]8AGAT 0,00185 











8 [TATC]8 [AATC]2 [ATCT]3 TTC [TGTC]2 0,14259 
9 [TATC]9 [AATC]2 [ATCT]3 TTC [TGTC]2 0,07593 
10 [TATC]10 [AATC]2 [ATCT]3 TTC [TGTC]2 0,05741 
10 [TATC]10 [TATC][AATC][ATCT]3 TTC [TGTC]2 0,01667 
10 [TATC]10 [TATC]2 [AATC][ATCT]2 TTC [TGTC]2 0,00093 
11 [TATC]11 [AATC]2 [ATCT]3 TTC [TGTC]2 0,10463 
11 [TATC]11 [TATC][AATC][ATCT]3 TTC [TGTC]2 0,16111 
11 [TATC]11 [TATC]2 [ATCT]3 TTC [TGTC]2 0,00093 
12 [TATC]12 [AATC]2 [ATCT]3 TTC [TGTC]2 0,15370 
12 [TATC]12 [TATC][AATC][ATCT]3 TTC [TGTC]2 0,13796 
13 [TATC]13 [AATC]2 [ATCT]3 TTC [TGTC]2 0,07222 
13 [TATC]13 [TATC][AATC][ATCT]3 TTC [TGTC]2 0,03241 
14 [TATC]14 [AATC]2 [ATCT]3 TTC [TGTC]2 0,03056 
14 [TATC]14 [TATC][AATC][ATCT]3 TTC [TGTC]2 0,01019 
15 [TATC]15 [AATC]2[ATCT]3 TTC [TGTC]2 0,00185 











8 [GATA]8 0,01204 
9 [GATA]9 0,14167 
10 [GATA]10 0,07315 
11 [GATA]11 0,30093 
12 [GATA]12 0,25648 
12 [GATA][GAGA][GATA]10 0,00093 
13 [GATA]13 0,18426 
14 [GATA]14 0,02870 












7 [AGAT]7 0,00093 
9 [AGAT]9 0,00093 
10 [AGAT]10 0,02035 
11 [AGAT]11 0,29602 
11 [AGAT]10[CGAT] 0,00093 
12 [AGAT]12 0,44496 
12 [AGAT]11[CGAT] 0,00185 
12 [AGAT]10[AGGT][AGAT] 0,00093 
13 [AGAT]13 0,18686 
13,3 [AGAT]3GAT[AGAT]10 0,00093 
14 [AGAT]14 0,04163 














7 [AGAA]7 AAAG AGAG AG 0,00093 
9 [AGAA]9 AAAG AGAG AG 0,00093 
10 [AGAA]10 AAAG AGAG AG 0,01296 
11 [AGAA]11 AAAG AGAG AG 0,00741 
12 [AGAA]12 AAAG AGAG AG 0,13519 
13 [AGAA]13 AAAG AGAG AG 0,12315 
14 [AGAA]14 AAAG AGAG AG 0,18241 
14 [AGAA][AGCA][AGAA]12 AAAG AGAG AG 0,00370 
15 [AGAA]15 AAAG AGAG AG 0,13611 
16 [AGAA]16 AAAG AGAG AG 0,12037 
17 [AGAA]17 AAAG AGAG AG 0,12222 
18 [AGAA]18 AAAG AGAG AG 0,07315 
19 [AGAA]19 AAAG AGAG AG 0,04074 
20 [AGAA]20 AAAG AGAG AG 0,01481 
21 [AGAA]21 AAAG AGAG AG 0,01296 
22 [AGAA]22 AAAG AGAG AG 0,00741 
23 [AGAA]23 AAAG AGAG AG 0,00278 
24 [AGAA]24 AAAG AGAG AG 0,00093 
25 [AGAA]25 AAAG AGAG AG 0,00185  









10 [AAGG][AAAG][AAGG][TAGG][AAGG]8 AGAG AGGA AGAA AGAG AG 0,00463 
11 [AAGG][AAAG][AAGG][TAGG][AAGG]9 AGAG AGGA AGAA AGAG AG 0,00278 
12 [AAGG][AAAG][AAGG][TAGG][AAGG]7[AAAG][AAGG]2 AGAG AGGA AGAA AGAG AG 0,00093 
12 [AAGG][AAAG][AAGG][TAGG][AAGG]10 AGAG AGGA AGAA AGAG AG 0,06759 
12,2 [AAGG][AA][AAGG][TAGG][AAGG]11 AGAG AGGA AGAA AGAG AG 0,00370 
13 [AAGG][AAAG][AAGG][TAGG][AAGG]11 AGAG AGGA AGAA AGAG AG 0,22685 
13,2 [AAGG][AA][AAGG][TAGG][AAGG]12 AGAG AGGA AGAA AGAG AG 0,01759 
14 [AAGG][AAAG][AAGG][TAGG][AAGG]12 AGAG AGGA AGAA AGAG AG 0,00833 
14 [AAGG][AAAG][AAGG][AAGG][AAGG]12 AGAG AGGA AGAA AGAG AG 0,35556 
14,2 [AAGG][AA][AAGG][TAGG][AAGG]13 AGAG AGGA AGAA AGAG AG 0,01667 
15 [AAGG][AAAG][AAGG][TAGG][AAGG]13 AGAG AGGA AGAA AGAG AG 0,18796 
15,2 [AAGG][AA][AAGG][TAGG][AAGG]14 AGAG AGGA AGAA AGAG AG 0,04907 
16 [AAGG][AAAG][AAGG][TAGG][AAGG]14 AGAG AGGA AGAA AGAG AG 0,03704 
16,2 [AAGG][AA][AAGG][TAGG][AAGG]15 AGAG AGGA AGAA AGAG AG 0,01852 
17 [AAGG][AAAG][AAGG][TAGG][AAGG]15 AGAG AGGA AGAA AGAG AG 0,00093 
17,2 [AAGG][AA][AAGG][TAGG][AAGG]16 AGAG AGGA AGAA AGAG AG 0,00093 












9 [TAGA]9 [TG]5  0,00093 
10 [TAGA]9 TAGG [TG]5  0,00093 
11 [TAGA]11 [TG]5 0,07315 
11 [TAGA]10 TAGG [TG]5  0,00556 
12 [TAGA]12 [TG]5  0,05278 
12 [TAGA]11 TAGG [TG]5  0,06481 
13 [TAGA]13 [TG]5  0,02870 





13 [TAGA]11 TAGC TAGA [TG]5 0,00278 
14 [TAGA]13 TAGG [TG]5 0,07407 
14 [TAGA]14 [TG]5  0,01019 
14 [TAGA]12 TAGC TAGA [TG]5 0,00093 
14,3 [TAGA]2 TGA [TAGA]11 TAGG [TG]5 0,00093 
14,3 [TAGA]4 TGA [TAGA]9 TAGG [TG]5 0,00093 
15 [TAGA]14 TAGG [TG]5 0,13056 
15 [TAGA]15 [TG]5  0,00185 
15,3 [TAGA]4 TGA [TAGA]10 TAGG [TG]5 0,04074 
15,3 [TAGA]3 TGA [TAGA]11 TAGG [TG]5  0,03148 
15,3 TAGA]2 TGA [TAGA]12 TAGG [TG]5   0,00093 
16 [TAGA]15 TAGG [TG]5  0,11667 
16 [TAGA]15 TAAG [TG]5   0,00556 
16,3 [TAGA]4 TGA [TAGA]11 TAGG [TG]5 0,06389 
16,3 [TAGA]3 TGA [TAGA]12 TAGG [TG]5 0,00093 
17 [TAGA]16 TAGG [TG]5 0,03889 
17,3 [TAGA]4 TGA [TAGA]12 TAGG [TG]5 0,15556 
18 [TAGA]17 TAGG [TG]5 0,00185 
18,3 [TAGA]4 TGA [TAGA]13 TAGG [TG]5 0,05741 
19 [TAGA]18 TAGG [TG]5 0,00093 
19,3 [TAGA]4 TGA [TAGA]14 TAGG [TG]5 0,01204 
20,3 [TAGA]4 TGA [TAGA]14 TAGG [TG]5 0,00093  








9 [AGAT]9 0,00926 
10 [AGAT]10 0,00093 
11 [AGAT]11 0,02500 
12 [AGAT]12 0,02222 
13 [AGAT]13 0,22685 
14 [AGAT]14 0,44167 
15 [AGAT]15 0,20833 
16 [AGAT]16 0,06296 
17 [AGAT]17 0,00278 
  







24,2 [TCTA]5[TCTG]6[TCTA]3TCA[TCTA]2TCCATA[TCTA]9 0,00093 
26 [TCTA]4[TCTG]6[TCTA]3TA[TCTA]3TCA[TCTA]2TCCATA[TCTA]8 0,00370 
27 [TCTA]6[TCTG]5[TCTA]3TA[TCTA]3TCA[TCTA]2TCCATA[TCTA]8 0,02685 
27 [TCTA]4[TCTG]6[TCTA]3TA[TCTA]3TCA[TCTA]2TCCATA[TCTA]9 0,00741 
28 [TCTA]6[TCTG]5[TCTA]3TA[TCTA]3TCA[TCTA]2TCCATA[TCTA]9 0,00370 
28 [TCTA]5[TCTG]6[TCTA]3TA[TCTA]2TCA[TCTA]2TCCATA[TCTA]10 0,00093 
28 [TCTA]4[TCTG]6[TCTA]3TA[TCTA]3TCA[TCTA]2TCCATA[TCTA]10 0,19537 
28 [TCTA]4[TCTG]7[TCTA]3TA[TCTA]3TCA[TCTA]2TCCATA[TCTA]9 0,00093 
29 [TCTA]6[TCTG]5[TCTA]3TA[TCTA]3TCA[TCTA]2TCCATA[TCTA]10 0,04352 
29 [TCTA]5[TCTG]5[TCTA]3TA[TCTA]3TCA[TCTA]2TCCATA[TCTA]11 0,00093 
29 [TCTA]5[TCTG]6[TCTA]3TA[TCTA]3TCA[TCTA]2TCCATA[TCTA]10 0,00370 





29,2 [TCTA]5[TCTG]5[TCTA]3TA[TCTA]3TCA[TCTA]2TCCATA[TCTA]10TATCTA 0,00093 
30 [TCTA]7[TCTG]5[TCTA]3TA[TCTA]3TCA[TCTA]2TCCATA[TCTA]10 0,00463 
30 [TCTA]6[TCTG]5[TCTA]3TA[TCTA]3TCA[TCTA]2TCCATA[TCTA]11 0,11852 
30 [TCTA]6[TCTG]6[TCTA]3TA[TCTA]3TCA[TCTA]2TCCATA[TCTA]10 0,00093 
30 [TCTA]5[TCTG]6[TCTA]3TA[TCTA]3TCA[TCTA]2TCCATA[TCTA]11 0,05741 
30 [TCTA]4[TCTG]6[TCTA]3TA[TCTA]3TCA[TCTA]2TCCATA[TCTA]12 0,05648 
30,2 [TCTA]5[TCTG]5[TCTA]3TA[TCTA]3TCA[TCTA]2TCCATA[TCTA]11TATCTA 0,00926 
30,2 [TCTA]5[TCTG]6[TCTA]3TA[TCTA]3TCA[TCTA]2TCCATA[TCTA]10TATCTA 0,02870 
31 [TCTA]7[TCTG]5[TCTA]3TA[TCTA]3TCA[TCTA]2TCCATA[TCTA]11 0,00741 
31 [TCTA]6[TCTG]5[TCTA]3TA[TCTA]3TCA[TCTA]2TCCATA[TCTA]12 0,02685 
31 [TCTA]5[TCTG]6[TCTA]3TA[TCTA]3TCA[TCTA]2TCCATA[TCTA]12 0,02407 
31 [TCTA]4[TCTG]6[TCTA]3TA[TCTA]3TCA[TCTA]2TCCATA[TCTA]13 0,01296 
31,2 [TCTA]5[TCTG]5[TCTA]3TA[TCTA]3TCA[TCTA]2TCCATA[TCTA]12TATCTA 0,00093 
31,2 [TCTA]5[TCTG]6[TCTA]3TA[TCTA]3TCA[TCTA]2TCCATA[TCTA]11TATCTA 0,07222 
32 [TCTA]7[TCTG]5[TCTA]3TA[TCTA]3TCA[TCTA]2TCCATA[TCTA]12 0,00093 
32 [TCTA]6[TCTG]5[TCTA]3TA[TCTA]3TCA[TCTA]2TCCATA[TCTA]13 0,00093 
32 [TCTA]5[TCTG]6[TCTA]3TA[TCTA]3TCA[TCTA]2TCCATA[TCTA]13 0,00556 
32 [TCTA]4[TCTG]6[TCTA]3TA[TCTA]3TCA[TCTA]2TCCATA[TCTA]14 0,00185 
32,2 [TCTA]5[TCTG]6[TCTA]3TA[TCTA]3TCA[TCTA]2TCCATA[TCTA]12TATCTA 0,06667 
33 [TCTA]7[TCTG]5[TCTA]3TA[TCTA]3TCA[TCTA]2TCCATA[TCTA]13 0,00093 
33,2 [TCTA]5[TCTG]6[TCTA]3TA[TCTA]3TCA[TCTA]2TCCATA[TCTA]13TATCTA 0,03241 
34 [TCTA]10[TCTG]5[TCTA]3TA[TCTA]3TCA[TCTA]2TCCATA[TCTA]11 0,00093 
34,2 [TCTA]5[TCTG]6[TCTA]3TA[TCTA]3TCA[TCTA]2TCCATA[TCTA]14TATCTA 0,00556 












8 [ATT]5 ACT [ATT]2 0,00185 
11 [ATT]8 ACT [ATT]2 0,13981 
12 [ATT]9 ACT [ATT]2 0,01852 
13 [ATT]10 ACT [ATT]2 0,00278 
14 [ATT]11 ACT [ATT]2 0,03981 
15 [ATT]12 ACT [ATT]2 0,37222 
16 [ATT]13 ACT [ATT]2 0,33426 
17 [ATT]14 ACT [ATT]2 0,08426 
17 ATG [ATT]13 ACT [ATT]2 0,00093 
18 [ATT]15 ACT [ATT]2 0,00463 












16 [TGCC]6 [TTCC]10 0,04259 
16 [TGCC]5 [TTCC]11 0,00093 
17 [TGCC]6 [TTCC]11 0,18519 
17 [TGCC]5 [TTCC]12 0,00185 
18 [TGCC]7 [TTCC]11 0,03426 
18 [TGCC]6 [TTCC]12 0,06759 





19 [TGCC]8 [TTCC]11 0,00093 
19 [TGCC]7 [TTCC]12 0,11019 
19 [TGCC]6 [TTCC]13 0,02685 
19 [TGCC]6 [TTCC]10 [GTCC] [TTCC]2 0,00093 
20 [TGCC]7 [TCCC] [TTCC]12  0,01944 
20 [TGCC]7 [TTCC]10 [GTCC] [TTCC]2 0,02963 
20 [TGCC]7 [TTCC]13 0,08426 
20 [TGCC]7 [TTCC]2 [TTTC] [TTCC]10 0,00278 
20 [TGCC]6 [TTCC]14 0,01204 
20 [TGCC]7 [TCCC] [TTCC]13 0,00093 
21 [TGCC]7 [TTCC]11 [GTCC] [TTCC]2 0,00556 
21 [TGCC]7 [TTCC]14  0,01574 
21 [TGCC]8 [TTCC]11 [GTCC] [TTCC]2 0,00093 
22 [TGCC]7 [TTCC]12 [GTCC] [TTCC]2 0,02593 
22 [TGCC]7 [TTCC]15  0,00370 
22 [TGCC]6 [TTCC]13 [GTCC] [TTCC]2 0,00278 
22 [TGCC]7 [TTCC]13 [GTCC] [TTCC]2 0,10556 
23 [TGCC]6 [TTCC]14 [GTCC] [TTCC]2 0,00278 
23 [TGCC]8 [TTCC]13 [GTCC] [TTCC]2 0,00556 
24 [TGCC]7 [TTCC]14 [GTCC] [TTCC]2 0,07870 
24 [TGCC]6 [TTCC]15 [GTCC] [TTCC]2 0,00833 
24 [TGCC]5 [TTCC]16 [GTCC] [TTCC]2 0,00093 
25 [TGCC]8 [TTCC]14 [GTCC] [TTCC]2 0,01389 
25 [TGCC]7 [TTCC]15 [GTCC] [TTCC]2 0,08796 
25 [TGCC]6 [TTCC]16 [GTCC] [TTCC]2 0,00093 
26 [TGCC]8 [TTCC]15 [GTCC] [TTCC]2 0,00093 
26 [TGCC]7 [TTCC]16 [GTCC] [TTCC]2 0,01667 
26 [TGCC]6 [TTCC]17 [GTCC] [TTCC]2 0,00093 










9,1 A[TCAT]9 0,00093 
10 [TCAT]10 0,06852 
10 [TCTA]8[TCTG][TCTA] 0,13704 
11 [TCTA]11 0,35741 
11 [TCTA]9[TCTG][TCTA]  0,00926 
11,3 [TCTA]4[TCA][TCTA]7  0,03241 
12 [TCTA]12 0,04259 
12 [TCTA]10[TCTG][TCTA]  0,00185 
12 [TCTA]9[TTTA][TCTA]2  0,00278 
13 [TCTA]13 0,01204 
13 [TCTA]11[TCTG][TCTA]  0,00093 
13 [TCTA]10[TTTA][TCTA]2  0,02222 
14 [TCTA]11[TTTA][TCTA]2  0,27037 
15 [TCTA]12[TTTA][TCTA]2  0,03333 


















11 TCTA [TCTG]2 [TCTA]8  0,00833 
13 TCTA [TCTG]2 [TCTA]10 0,00278 
14 TCTA TCTG [TCTA]12 0,00093 
14 TCTA [TCTG]2 [TCTA]11  0,08611 
15 TCTA TCTG [TCTA]13  0,02593 
15 TCTA [TCTG]2 [TCTA]12 0,24167 
15 TCTA [TCTG]3 [TCTA]11  0,00648 
16 TCTA TCTG [TCTA]14 0,01481 
16 TCTA [TCTG]2 [TCTA]13 0,17037 
16 TCTA [TCTG]3 [TCTA]12  0,07685 
17 TCTA TCTG [TCTA]15 0,00185 
17 TCTA [TCTG]2 [TCTA]14 0,11296 
17 TCTA [TCTG]3 [TCTA]13  0,08704 
17 TCTA [TCTG]4 [TCTA]12  0,00185 
18 TCTA [TCTG]2 [TCTA]15  0,02222 
18 TCTA [TCTG]3 [TCTA]14 0,12130 
19 TCTA [TCTG]2 [TCTA]16 0,00185 
19 TCTA [TCTG]3 [TCTA]15  0,01296 


















8 [ATCT]8 0,25278 
9 [ATCT]9 0,31296 
9 [ATCT] GTCT [ATCT]7 0,02593 
10 [ATCT]10 0,22037 
11 [ATCT]11 0,17315 











7 [AGAT]7[AGAG] 0,00278 
8 [AGAT]8[AGAG] 0,00093 
8 [AGAT]8[AGAT] 0,00093 
9 [AGAT]9[AGAG] 0,04259 
9 [AGAT]9[AGAT] 0,00093 
10 [AGAT]10[AGAG] 0,04444 
10 [AGAT]10[AGAT] 0,01481 
11 [AGAT]11[AGAG] 0,37500 
11 [AGAT]11[AGAT] 0,02685 
12 [AGAT]12[AGAG] 0,21759 
12 [AGAT]12[AGAT] 0,10278 
13 [AGAT]13[AGAG] 0,12037 
13 [AGAT]13[AGAT] 0,04074 
14 [AGAT]14[AGAG] 0,00648 
















11 [AGAT]11 0,33611 
12 [AGAT]12 0,23241 
13 [AGAT]13 0,07037 
14 [AGAT]14 0,05833 
15 [AGAT]15 0,00648 
15 [AGAT]13[ACAT][AGAT] 0,00463 
15 [AGAT]9[ACAT][AGAT]5 0,00093 
16 [AGAT]14[ACAT][AGAT] 0,00278 
17 [AGAT]11[ACAT][AGAT]5 0,04907 
18 [AGAT]12[ACAT][AGAT]5 0,06574 
19 [AGAT]13[ACAT][AGAT]5 0,10370 
20 [AGAT]13[ACAT][AGAT]6 0,00278 
20 [AGAT]14[ACAT][AGAT]5 0,04537 
21 [AGAT]14[ACAT][AGAT]6 0,00556 
21 [AGAT]15[ACAT][AGAT]5 0,00370 
23 [AGAT]11[ACAT][AGAT]4[ACAT][AGAT]6 0,00093  








6 [GATA]6 GACA GATT GATA GTTT 0,00093 
7 [GATA]7 GACA GATT GATA GTTT 0,01852 
8 [GATA]8 GACA GATT GATA GTTT 0,14722 
9 [GATA]9 GACA GATT GATA GTTT 0,16667 
10 [GATA]10 GACA GATT GATA GTTT 0,22407 
11 [GATA]11 GACA GATT GATA GTTT 0,22222 
11,1 [GATA]11 A GACA GATT GATA GTTT 0,00741 
12 [GATA]12 GACA GATT GATA GTTT 0,16204 
13 [GATA]13 GACA GATT GATA GTTT 0,04352 
14 [GATA]14 GACA GATT GATA GTTT 0,00648 











8 [TCTA]8 0,00926 
9 [TCTA]9 0,01204 
10 [TCTA]10 0,08333 
11 [TCTA]11 0,07130 
12 [TCTA]12 0,11852 
12 [TCTA] [TCTG] [TCTA]10 0,00926 
13 [TCTA]13 0,08426 
13 [TCTA]2 [TCTG] [TCTA]10  0,00556 
13 [TCTA] [TCTG] [TCTA]11 0,24630 
13 [TCTA] [TCTG]2 [TCTA]10  0,00093 
14 [TCTA]14 0,03056 
14 [TCTA]2 [TCTG] [TCTA]11  0,05000 
14 [TCTA] [TCTG] [TCTA]12  0,12870 
14 [TCTA] [TCTG] [TGTA] [TCTA]11 0,00833 
15 [TCTA]15 0,00093 
15 [TCTA]2 [TCTG] [TCTA]12  0,06019 





16 [TCTA]2 [TCTG] [TCTA]13 0,02778 
16 [TCTA]2 [TCTG]2 [TCTA]12 0,00185 
16 [TCTA] [TCTG] [TCTA]14 0,00278 
17 [TCTA]2 [TCTG]2 [TCTA]13 0,00093 











9 TAGA TCGA [TAGA]7 0,00093 
10 TAGA TCGA [TAGA]8 0,00926 
10 [TAGA]10 0,02685 
11 [TAGA]11 0,15926 
11 TAGA TCGA [TAGA]9 0,06574 
12 [TAGA]12 0,16667 
12 TAGA TCGA [TAGA]10 0,20185 
13 [TAGA]13 0,05833 
13 TAGA TCGA [TAGA]11 0,25463 
13 TAGA TCGA [TAGA]2 TAGT [TAGA]8 0,00185 
14 [TAGA]14 0,00741 
14 TAGA TCGA [TAGA]12 0,03981 
15 [TAGA]15 0,00185 
15 TAGA TCGA [TAGA]13 0,00185 








17 [TTTC]3[TTTT][TTCT][CTTT]9[CTCC][TTCC]2  0,00093 
18 [TTTC]3[TTTT][TTCT][CTTT]10[CTCC][TTCC]2  0,02037 
18,2 [TTTC]3[TTTT][TT][CTTT]11[CTCC][TTCC]2  0,00093 
19 [TTTC]3[TTTT][TTCT][CTTT]11[CTCC][TTCC]2  0,05370 
19,2 [TTTC]3[TTTT][TT][CTTT]12[CTCC][TTCC]2  0,00093 
20 [TTTC]3[TTTT][TTCT][CTTT]12[CTCC][TTCC]2  0,14444 
21 [TTTC]3[TTTT][TTCT][CTTT]13[CTCC][TTCC]2  0,19352 
21,2 [TTTC]3[TTTT][TT][CTTT]14[CTCC][TTCC]2  0,00463 
22 [TTTC]3[TTTT][TTCT][CTTT]14[CTCC][TTCC]2  0,18333 
22,2 [TTTC]3[TTTT][TT][CTTT]15[CTCC][TTCC]2  0,00741 
23 [TTTC]3[TTTT][TTCT][CTTT]15[CTCC][TTCC]2 0,14630 
23,2 [TTTC]3[TTTT][TT][CTTT]16[CTCC][TTCC]2  0,00370 
23,3 [TTTC]3[TTTT][TTCT][CTTT]14[CTT][CTTT][CTCC][TTCC]2  0,00093 
24 [TTTC]3[TTTT][TTCT][CTTT]16[CTCC][TTCC]2  0,13611 
24,2 [TTTC]3[TTTT][TT][CTTT]17[CTCC][TTCC]2  0,00093 
25 [TTTC]3[TTTT][TTCT][CTTT]15 GTTT  CTTT [CTCC][TTCC]2  0,06759 
25 [TTTC]3[TTTT][TTCT][CTTT]17[CTCC][TTCC]2  0,00278 
26 [TTTC]3[TTTT][TTCT][CTTT]18[CTCC][TTCC]2  0,02407 
27 [TTTC]3[TTTT][TTCT][CTTT]19[CTCC][TTCC]2  0,00556 









 2,2 GAAAAGA[AAAGA]2 0,00093 
6 AAAAG [AAAGA]6 0,01111 





8 AAAAG [AAAGA]8 0,01759 
9 AAAAG [AAAGA]9 0,20648 
10 AAAAG [AAAGA]10 0,13426 
11 AAAAG [AAAGA]11 0,11389 
12 AAAAG [AAAGA]12 0,24815 
13 AAAAG [AAAGA]13 0,18241 
14 AAAAG [AAAGA]14 0,06019 
14,1 AAAAG [AAAGA]3 A[AAAGA]11 0,00185 
15 AAAAG [AAAGA]15 0,01296 
16 AAAAG [AAAGA]16 0,00093 










5 [AAAGA]5 0,07315 
7 [AAAGA]7 0,15370 
8 [AAAGA]8 0,01204 
9 [AAAGA]9 0,02037 
10 [AAAGA]10 0,09630 
11 [AAAGA]11 0,10093 
12 [AAAGA]12 0,16481 
13 [AAAGA]13 0,06481 
14 [AAAGA]14 0,06019 
15 [AAAGA]15 0,06019 
16 [AAAGA]16 0,07407 
17 [AAAGA]17 0,05926 
18 [AAAGA]18 0,02593 
19 [AAAGA]19 0,01574 
20 [AAAGA]20 0,00463 
21 [AAAGA]21 0,01389  





5 [AATG]5 0,00093 
6 [AATG]6 0,21667 
7 [AATG]7 0,20185 
8 [AATG]8 0,09630 
9 [AATG]9 0,14352 
9,3 [AATG]6[ATG][AATG]3  0,33426 








6 [AATG]6 0,00093 
7 [AATG]7 0,00093 
8 [AATG]8 0,51111 
9 [AATG]9 0,09630 
10 [AATG]10 0,06019 
11 [AATG]11 0,29074 


















13 [TCTA]2 [TCTG]4 [TCTA]3 [TCCA] [TCTA]3 TCCA TCCA     0,00093 
14 [TCTA] [TCTG] [TCTA] [TCTG]4[TCTA]3[TCCA][TCTA]3 TCCA TCCA  0,06296 
14 [TCTA] [TCTG]3[TCTA]10 TCCA TCTA 0,01667 
14 [TCTA] [TCTG]4[TCTA]9 TCCA TCTA 0,00278 
15 [TCTA] [TCTG] [TCTA] [TCTG]4[TCTA]3[TCCA] [TCTA]3[TCCA] TCCA TCCA  0,00185 
15 [TCTA] [TCTG]3[TCTA]11 TCCA TCTA  0,05926 
15 [TCTA] [TCTG]4[TCTA]10 TCCA TCTA  0,01944 
16 [TCTA] [TCTG]3[TCTA]12 TCCA TCTA  0,03241 
16 [TCTA] [TCTG]4[TCTA]11 TCCA TCTA  0,15556 
16 [TCTG]4[TCTA]12 TCCA TCTA  0,00093 
17 [ACTA] [TCTG]4[TCTA]12 TCCA TCTA  0,00093 
17 [TCTA] [TCTG]3[TCTA]13 TCCA TCTA  0,02130 
17 [TCTA] [TCTG]4[TCTA]12 TCCA TCTA  0,27963 
18 [TCTA] [TCTG]3[TCTA]14 TCCA TCTA  0,00556 
18 [TCTA] [TCTG]4[TCTA]13 TCCA TCTA  0,19722 
18 [TCTA] [TCTG]5[TCTA]12 TCCA TCTA  0,00648 
19 [TCTA] [TCTG]3[TCTA]15 TCCA TCTA  0,00185 
19 [TCTA] [TCTG]4[TCTA]14 TCCA TCTA  0,10000 
19 [TCTA] [TCTG]5[TCTA]13 TCCA TCTA  0,00185 
19 [TCTA] [TCTG]6[TCTA]12 TCCA TCTA  0,00093 
20 [TCTA] [TCTG]4[TCTA]15 TCCA TCTA  0,02685 









Table 1: List of individual sequence-based alleles observed in the population studied. Novel variants are highlighted in 
red and in bold, whilst allele designations that do not follow ISFG recommendations are marked with an asterisk. 
Flanking region sequences reported by the software are highlighted in light grey to avoid confusion with repeat region 
sequences. 
